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ABSTRACT
Plant viruses have been highlighted among material research due to their well-defined
structures in nanoscale, mono-dispersity, stability, and chemical functionalities. Each of
the thousands coated protein subunits on a viral nanoparticle can be homogenously
modified, chemically, and genetically with a functional ligand leading to a high-density
and spatial distribution of ligands on each particle (multivalency). Many reports from our
group have clearly shown that virus coated substrates induced the acceleration of bone
marrow stromal cells differentiation into bone cells. We hypothesized that this
phenomenon could rely on the multivalency that the viral nanoparticle has to offer.
Moving to a more clinical relevant application, we fabricated three-dimensional (3D)
biopolymeric scaffolds with functionalized rod-like Tobacco mosaic virus (TMV) for
tissue engineering. The virus-functionalized hydrogel materials were developed and
characterized. The first three chapters present in vitro and in vivo data based on the
sponge-like preformed hydrogel functionalized with the cellular recognition peptide,
arginine-glycine-aspartic acid (RGD), through an incorporation of RGD mutant of TMV
(TMV-RGD1). Chapter 6 describes the development of an in situ crosslinking injectable
hydrogel using cysteine-addition mutant of TMV (TMV-1Cys).
First chapter includes the fabrication method for TMV-incorporated porous
alginate hydrogel, in vitro stem cell culture in 3D, and in vitro bone differentiation of
stem cell in the hydrogel. TMV-RGD1 was non-covalently incorporated to introduce the

vi

biofunctionality into the hydrogel. This hydrogel was a preformed scaffold in which stem
cells were seeded after the gel was fabricated. Cell attachment, viability were then
characterized to assure the presence and accessibility of the RGD peptide on the virus
scaffold. Osteogenic differentiation of bone marrow stromal cells was assessed in the
composite hydrogels. The virus and its mutant modification with bio-adhesive peptide
(RGD) significantly improved cell attachments and afforded a higher level of calcium
depositions in comparison to the unmodified hydrogel. The TMV-functionalized
hydrogel scaffolds were also used to study cartilage differentiation of bone marrow
stromal cells in chapter 5. In chapter 2, in vivo biocompatibility studies of the hydrogel
scaffolds, functionalized with wild-type and RGD-mutant TMV, showed no systemic
toxicity and insignificant immune response against virus-modified hydrogel implants in
the BALB/c mice. Chapter 3 confirms the in vivo biocompatibility of the hydrogel
scaffolds with TMV and its RGD-mutant when bone marrow stromal cells were
incorporated in the implants. Moreover, the implanted hydrogels guided the bone
regeneration and could consequently repaired cranial defects in laboratory rats, as
presented in chapter 4.
In chapter 6, cys-mutant of TMV was used to covalently link the virus particles
with methacrylated polymer backbone through Michael addition reaction in the injectable
hydrogel. In this system, physical properties of the hydrogel; for example, gelation time
and gel moduli could be finely tuned via the degree of methacrylation and/or the addition
of the virus. This in situ crosslinking method and the resulting hydrogel was
cytocompatible for encapsulation and cultivation of bone marrow stromal cells.

vii

Taken together, this dissertation articulates the application of using virus
nanoparticles in functionalization and development of hydrogels as biomaterials for 3D
cell culture and differentiation, as well as bone substitute matrix. These findings
demonstrated that the virus-functionalized hydrogels can be promising materials for
tissue engineering.
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CHAPTER 1
POROUS ALGINATE HYDROGEL FUNCTIONALIZED WITH TOBACCO MOSAIC VIRUS AS
THREE-DIMENSIONAL SCAFFOLDS FOR BONE DIFFERENTIATION1
1.1 INTRODUCTION
1.1.1 Hydrogels as biomaterials for tissue engineering
The key challenges in making off-the-shelf tissue-engineered organs include providing
sufficient oxygen and nutrient exchange to engineered tissue constructs with pore size
larger than 100 μm, selecting a suitable cell type, and creating advance architecture of
matrix to support the tissue.1-3 Hydrogels, as three dimensional (3D) scaffolds mimicking
the natural extracellular environment of cells, have great potential for tissue engineering
applications. A carefully designed hydrogel system can offer the ideal support4 for
microvasculature and tissues, as well as the possible equilibration to high, tissue-like
water content.5 The presence of water and the porous structure allows for the influx of
low molecular weight solutes and nutrients crucial for cell viability, as well as the
transport of cellular waste out of the hydrogel.6, 7 In addition, different functional groups
can be attached to the hydrogel skeleton to impart desirable physical, chemical, and cell
responsive properties to serve different biomedical applications.8-10

1

The content in this chapter was modified from Luckanagul J, Lee LA, Nguyen QL, Sitasuwan P, Yang X,
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Copyright (2012) American Chemical Society.
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1.1.2 Roles of virus particles in extracellular matrix designed to control cell behavior
Despite extensive work with peptide conjugates in hydrogels, there are limited studies
showing the functionalization of hydrogels with multivalent (multipoint contact)
materials. Past studies have shown that complex toxins (e.g., heptavalent protective
antigen from anthrax), immune complexes, and surface receptor clusters that reflect the
multivalent interactions between the host cell surface receptors and the binding agents are
important for cell dynamics.11-13 To modulate the cellular responses, ligands specific to
cell surface receptors are crucial, but studies also suggest that ligand density, the spatial
presentation of ligands, and the physical and mechanical properties of the hydrogels all
play critical roles.8-10, 14, 15 Based on previous studies, coating 2D substrates with TMV
demonstrated enhanced osteogenic differentiation potentials.16 The results from these
earlier studies indicated that the surface coating with viral particles was essential to
accelerate differentiation from 21 to 14 days and supplementing the media with virus
particles failed to induce a similar enhanced differentiation.17 While the interaction
between TMV, substrate, and mesenchymal stem cells on 2D substrates appears critical
for such an accelerated differentiation process, it is not known whether these similar
events can be translated to 3D scaffolds. Tobacco mosaic virus (TMV) is a rod-like plant
virus consisting of 2130 identical protein subunits arranged helically around a genomic
single-RNA strand. A TMV particle is roughly 300 nm long and 18 nm in diameter, with
a 4 nm cylindrical cavity along the central core.18, 19 TMV particles are multifaceted
nanosized building blocks, given its well-defined structure, genetic and chemical
modalities, and relative simplicity in its purification process. It has been used as a
primary building block to generate a programmable scaffold by chemical or genetic
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modification to decorate polyvalent functional motifs or peptide ligands with defined
density and distance between ligands.20-23 For example, TMV can be modified to display
certain functional units that promote cell adhesion, proliferation, and differentiation. In a
previous study the classical RGD (arginine−glycine−aspartic acid) peptide sequences
with different flanking sequencing were genetically engineered on the surface of the
TMV coat proteins to bind to the integrin receptors with differential adhesion strengths.24
A chemical modification approach can also be used to display phosphates or similar RGD
ligands via sequential modification of the tyrosine residue with a diazonium salt followed
by Cu(I)-catalyzed azide−alkyne cycloaddition reaction.23, 25 Here, we generated a 3D
scaffold that incorporates the virus particles without affecting the virus’s quaternary
structures in the porous hydrogels. The assembly of the porous hydrogel with the viral
particles required no covalent linkages between the alginate and TMV particles. A
genetically modified TMV particle was also used to enhance the cell loading capacity
within the hydrogels, and as a proof-of-concept, mesenchymal stem cells were seeded
and induced to osteogenic lineage.

1.1.3 Alginate as a hydrogel forming biopolymer
Alginate is a linear polysaccharide copolymer of (1−4)-linked β-D-mannuronic acid (M)
and α-L-guluronic acid (G) monomers that has been widely used in a variety of medical
applications. The choice for alginate hydrogel was due to its ability to form highly porous
hydrogels under mild conditions as well as its low toxicity and biodegradability.26-28
Alginate gels are formed when divalent cations (i.e., Ca2+) cooperatively interact with
blocks of G monomers to form ionic bridges between polymers.27-29 Unfortunately,
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alginate has limited bioactivity, meaning that the saccharide units do not specifically
interact with cell surface receptors.9 Covalent modifications of alginates to circumvent
this limitation have been well established via carbodiimide-mediated peptide coupling at
the carboxylic groups of which the activation step is nonselective to both G and M
residues. However, the covalent modification of G content reduces cross-linking sites,
thereby interfering with gelation.30 The modification of alginates could be realized by
incorporating large biomacromolecules, such as the virus particles, to generate embedded
functionalities without forming covalent modifications to the sugar backbone. In this
study, we prepared 3D porous hydrogels that can be functionalized by incorporating the
viral nanoparticles to enhance mesenchymal stem cell attachment, proliferation, and
differentiation. Given the mild synthetic conditions, we envision a range of functional
groups could be incorporated using virus libraries or other macromolecular assemblies in
these porous hydrogels.

1.2 RESULTS AND DISCUSSION
From the previous work, we have observed a significant shift in utilization of virus as
bionanoparticle scaffold to direct stem cell response.31 We have previously demonstrated
that TMV coated surfaces strikingly accelerated BMSCs bone differentiation in
comparison to conventional tissue culture polystyrene.32 Moreover, when a phosphate
group was chemically introduced to the TMV coat protein, the osteogenic differentiation
of BMSCs was more evident, as indicated by greater increase in osteocalcin mRNA
expression level.25 We proposed that the structural features of TMV played a role in the
improvement of stem cell differentiation. Continued efforts by Sitasuwan et al. indicated
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that an enhanced BMP2 expression at both mRNA and protein levels within 8 h of
osteoinduction was only for BMSCs cultured on TMV-coated surfaces and not when
TMV was supplemented in media.17 These findings have suggested the potential of
applying TMV as a scaffold to modulate the BMP2 regulation during early osteogenic
differentiation and potential osteogenic inducer for stem cells. In this regard, the
development of 3D matrices was deemed essential to determine similar enhanced
differentiation events observed with BMSCs on 2D scaffolds. In this study, we present an
economical, convenient, and versatile method of producing a fuctional 3D culture system
by incorporating the TMV particles. Our work is considered a pilot study and the first
reported method of noncovalent incorporation of TMV particles in 3D porous hydrogels.

1.2.1 Synthesis and characterization of porous alginate hydrogels
TMV was introduced into the hydrogel by adding the noninfectious virus particles during
the formation of gas templated, porous alginate hydrogels (PAH; Figure 1.1). The porous
alginate hydrogel was fabricated following the report by Barbetta et al., which provided
physical and mechanical parameters for potential use as 3D culture system.28 This
process did not require covalent modification or further purification, which reduced
concerns for protein deformation during covalent chemical conjugations and eliminated
the need to engineer reactive sites to incorporate the biological molecules in the
hydrogels. The initial homogeneous mixture of alginate in bicarbonate solution with low
concentration of surfactant (Pluronic F-108) is reacted with a mild acid (citric acid) to
generate CO2 in situ (Figure 1.1A). After the formation of the initial gas templated foamy
material, the virus is added as a solution to the mixture and the entire foamy material is

5

6

Figure 1.1. Synthetic procedure of generating virus functionalized porous composite hydrogels. Functionalization of composite
hydrogels for use in stem cell cultures can be achieved through direct mixing of virus solution to the foamy mixture of alginate. (A)
Alginate mixture comprised of low viscosity alginate, Pluronic F108, and sodium bicarbonate with an equivalent amount of citric acid
to generate gas template foamy mixture. (B) TMV was added 5 min before the foamy mixture was frozen and lyophilized. The
lyophilized sample was crosslinked with CaCl2. (C) Porous composite hydrogel was obtained after dialysis against 0.1 M CaCl2 and
lyophilization.

flash frozen then cross-linked. Additional dialysis and lyophilization steps provided the
final PAH functionalized with the virus particles. Developing 3D scaffolds for tissue
engineering, such materials need to have a range of macropores and proper size of
interconnecting channels that allow penetration of gas, nutrient and cellular infiltration.33,
34

Previous studies revealed that a pore size and an interconnecting channel of 100−300

and 40 μm, respectively, are essential for the cell survival and proliferation.28, 35 In this
porous alginate hydrogel, macropores were generated by in situ gas (CO2) generating
system composed of NaHCO3 and citric acid, suspended and stabilized by surfactant
(pluronic F108) with the help of high viscosity from 5% alginate until the mixture was
freeze-dried and cross-linked. PAH has provided a coarse structure for 3D cell housing
but lack the biofunctionalities in general. We fine-tuned the PAH by physically mixing
TMV particles during PAH synthesis. As a proof of concept, genetically engineered
TMV that precisely display integrin binding ligands, which we called TMV-RGD1,36, 37
was incorporated into the hydrogel mixture in the same way as TMV. The resulting
modified-PAH hydrogel successfully displayed RGD peptide sequences as indicated by
enhance cell attachment and cell viability. Similar to wild-type TMV, this RGD mutant
could be manufactured by the infected tobacco plants and easily purified in a very similar
procedure as wild-type TMV with high yields.24, 37, 38 The economical production of the
mutant TMV particles and the potential virus-based combinatorial functionalization of
3D material may prove to be useful for expanded material development.
The incorporation of the virus particle, its structural integrity, and its effects upon
the overall PAH formation (pore deformations, swelling property, and mechanical
property) was initially assessed by ESEM. The low magnification images obtained by
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ESEM revealed similar macropores and interconnecting channels ranging between 10 and
500 μm for both PAH (Figure 1.2A) and TMV-PAH (Figure 1.2C). These similarities
suggest that the addition of the virus did not hinder pore formation. The overall
architecture of the pores for PAH (Figure 1.2A) appeared to be more compact when
compared to the pores observed for TMV-PAH (Figure 1.2C). At a higher magnification,
PAH indeed shows smaller pores and denser networks (Figure 1.2B) than TMV-PAH,
whereas larger spherical pores (100−500 μm) were visible in TMV-PAH (Figure 1.2D).
These images indicate that the overall hydrogel formation (macropores and
interconnecting channels) is not hindered by the incorporation of the virus, which,
instead, can further facilitate the formation of large, well-defined pores. It is possible that
the addition of TMV stabilizes the interface between gas/liquid phase.39 TMV particles
could help trapping larger hydrophobic gas pockets upon the generation of CO2 to better
mediate the interfacial tension between aqueous and gas phases.
To verify this simple incorporation method and to confirm that the incorporated virus still
maintains its original rod-like structure, the existence of TMV intact particles in the
hydrogels after the entire synthesis process was observed under TEM. Addition of a
chelator, EDTA, was sufficient to de-crosslink the PAH and subsequently release the
viral particles to the solution. This de-crosslinking step was used to determine whether
the same amount of virus could be recovered from PAH, and whether the viral particles
were still structurally intact. The recycled TMV particles (Figure 1.2E) is similar in size
and shape under TEM in comparison to the TMV particles prior to incorporation (Figure
1.2F). UV−vis absorbance at 260 nm of the de-crosslinked TMV-PAH solution indicated
that nearly all virus particles could be retrieved after treating the hydrogel with EDTA
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Figure 1.2. (A-D) Scanning electron micrographs of hydrogels and TMV particles: (A)
and (B) PAH at different magnifications; (C) and (D) TMV-PAH at different
magnifications. The images of TMV-PAH reveal larger macropores and interconnecting
channels than PAH. Transmission electron micrographs of (E) intact TMV particles
released from TMV-PAH after decrosslinking with EDTA, and (F) purified native TMV
particles in buffer. Scale bars are 500 microns for (A) and (C), 100 microns for (B) and
(D) and 200 nm for (E) and (F).
9

(based on 0.1% TMV solution having an absorbance of 3 at 260 nm). A defining physical
characteristic of hydrogels is their swelling property that provides an aqueous
environment comparable to soft tissue. Both PAH and TMV-PAH hydrated 6−7 times
their original dry weight and was fully hydrated within 2 min (Figure 1.3A, B). A slight
increase in swelling ratio was observed during the 4-week incubation, which could
indicate a possible onset of the degradation of the scaffold, although such an observation
was not accompanied by a significant change in macroscopic dimension of the scaffold
(Figure 1.3C). Despite the lack of covalent conjugation of TMV to the alginate hydrogel,
the virus was stably integrated into the hydrogel. The amount of TMV released from
TMV-PAH into the aqueous solution was measured and it confirmed that most TMV
particles were entrapped in the hydrogel matrices even upon long-term incubation in
solution. The release profile derived from fluorescein-modified virus particles suggests
that dye modified TMV is slowly released from the hydrogel to a maximum 13% of its
original concentration after 24 h in solution and plateaued thereafter (Figure 1.3D). This
release profile may be reflective of any residual small dye molecules, broken particles, or
weakly embedded particles on the outer surface that are released to the solution. Future
studies probing this initial release profile with long-term release kinetics would be of
interest for time-controlled drug or biologics delivery platforms.
The mechanical properties of stem cell microenvironments are well-recognized as
essential determinants of differentiation fate. The mechanical factors that promote certain
stem cell fates can vary dramatically, with as much as 300-fold difference in elastic
modulus between matrices that favor soft brain tissue (0.1 kPa) and decalcifying bone
(>30 kPa).40 In our study, the impact of TMV nanoparticle inclusion on the mechanical
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Figure 1.3. Swelling property and stability of porous alginate hydrogels. (A) Both PAH
and TMV-PAH can absorb water and swell to the maximum within 2 min. (B) Total
masses of hydrogels soaked in water over time (fold increase of initial dry weight) are
constant and similar of both PAH (without TMV) and TMV-PAH (with TMV). (C)
Photographs of PAH soaked in water for 1 day, 14 days, and 28 days. (D) TMV releasing
profile shows the capability of TMV-PAH to maintain majority of the TMV nanoparticles
within the hydrogel.
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properties of PAH was assessed through unconfined compression testing. Regardless of
the irreversible water loss from the hydrated specimens during compression, stress versus
strain curves demonstrated that incorporation of virus in PAH induce a shift from a linear
to nonlinear mechanical response (Figure 1.4). The incremental elastic moduli extracted
from average stress−strain curves indicate that virus-modified materials are stiffer in the
lower strain regions (0−0.05), but more compliant at the higher strains (0.1−0.15; Table
1.1). These observations in mechanical properties may be explained by corresponding
effects on material pore architecture (Figure 1.2A−D), in which TMV inclusion caused an
increase in pore size. It is plausible that the alginate bulk is mechanically reinforced by
the inclusion of TMV particles (resulting in increased stiffness at low strains), but the
macroporous architecture begins to collapse at higher strains causing a reduction in
material stiffness.
In thermal analysis, while modulated differential scanning calorimetry (MDSC)
data supported the incorporation of virus particles into PAH, we showed that TMV did
not significantly impact the thermostability of original PAH, as indicated by
thermogravimetric analysis (TGA). As there were no covalent modifications on the
polymer chain structure, alginate still maintained their own properties and dominates as a
bulk material. The results showed similar decomposition profiles from TGA as well as
heat flow profiles obtained from MDSC in all three types of hydrogels (Figure 1.5). The
initial weight loss from TGA appeared to be water loss since the hydrogels are highly
hygroscopic. However, the major decomposition point started at 235−240 °C referring to
the decomposition of alginate, which is consistent with previous report.41 There were
slight variations in weight loss profiles that could possibly be caused by intrinsic water in
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Figure 1.4. The mechanical response of PAH, TMV-PAH, and RGD-PAH to unconfined
compression. PAH exhibited linear behavior, while both forms of virus modified PAHs
(TMV-PAH and RGD-PAH) induced nonlinearity at high strains (>0.1). Values
expressed are means (n=3) ± S.D.
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Table 1.1. Incremental elastic moduli of PAH, TMV-PAH, and RGD-PAH in two
compressive strain ranges (0-0.05 and 0.1-0.15). Values expressed are means (n=3) ±
S.D.

Strain range

Incremental Modulus (kPa)

PAH

TMV-PAH

RGD-PAH

0-0.05

103.92±23.10

183.01±13.09

146.56±7.49

0.1-0.15

123.71±13.15

31.17±6.03

49.47±13.15
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Figure 1.5. TGA (Termogravimetric analysis) characterization of porous composite
hydrogels. The porous composite hydrogels (A) PAH, (B) TMV-PAH, and (C) RGDPAH have similar weight-loss decomposition profiles
15

hydrogels. The thermal decomposition of TMV could not be observed from this
experiment, which is possible that the virus were decomposed in the same temperature
range as alginate. MDSC showed very broad endothermic peaks of the overall heat flow
profiles from all three types of hydrogels due to the dominance of amorphous
characteristic of hydrogels. The peak shift showing a combination of heat profiles from
PAH and TMV alone was observed on TMV-PAH, which was similar to the profile of
RGD-PAH. This could indicate some interaction occurring between virus particles and
PAH (Figure 1.6).

1.2.2 Cell attachment and cell viability in 3D virus-incorporated hydrogels
A number of studies have been done on modifying hydrogel scaffolds with peptide
sequence by peptide-polymer conjugation in order to probe substantial cell recognitions.
As the concept of multivalency effect in which intracellular cell machinery is believed to
be under integrative control of cell microenvironment by means of ligand density and
ligand orientation through oligomerized cell-surface receptors, the major threat of peptide
modifications is the lack of control over the spatial distribution of ligands displayed on
modified polymer in 3D system.42 Distinctively, we suggested the opportunity of using
virus nanoparticle to introduce the multivalency of ligands in 3D system. Our previous
experiment showed that the cell binding ligands on TMV-RGD1 mutant were exposed
and accessible for the cells.37 To demonstrate the potential use in cell cultures, cell
attachment, and viabilities were determined for the three types of hydrogels. Despite the
arrest in metabolic activity from a slow differentiation that might occur without the
specific induction in serum-rich condition, the hydrogels were shown to be safe for
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Figure 1.6. MDSC (Modulated Differential Scanning Calorimetry) characterization of
porous composite hydrogels. (A) An overlay total heat flow profile of PAH, TMV-PAH
and TMV alone showed the temperature shift on TMV-PAH as a combination of PAH
and TMV alone. (B) RGD-PAH showed similar total heat flow profiles with TMV-PAH.
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BMSCs culture because they survived and were able to grow in the PAH either with or
without the viral particles. In cell attachment assay, RGD-PAH (96 ± 1%) had
significantly higher cell attachment after 8 h of incubation than PAH (85 ± 3%). The
incorporation of TMV did not provide any significant improvement to cell attachment
when compared to the control (85 ± 1%; Figure 1.7A). Based on the metabolic assay with
CTB reagent, the cell viabilities in all three different types of hydrogels were determined
for days 8 and 14 cultures and normalized to metabolic rates of cells in PAH (Figure
1.7B). The results indicate that BMSCs survived in both virus modified PAHs (TMVand RGD-PAH) and the cells cultured on RGD-PAH continued to have the highest
metabolic activity (Figure 1.7B). However, there was no further increase in metabolically
active viable cells from day 8 to day 14. One possible explanation is that the change in
metabolic activity of cells due to the differentiation also occurred slowly without
osteogenic induction supplements in TMV-PAH and RGD-PAH. This explanation was
supported by the previous report from our group, which tested on a TMV-coated
substrate.17 Despite the lower attachment numbers and cell numbers for PAH and TMVPAH samples, the cells could penetrate deeply into the hydrogel, as indicated by ESEM
analysis (Figure 1.8). The morphology of the cells was visualized by ESEM in which the
BMSCs adhered and spread out for both PAH (Figure 1.8A) and TMV-PAH (Figure
1.8B). The same morphology and spreading of adherent cells is observed for cells
cultured in RGD-PAH.
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Figure 1.7. Cell attachment and viability in different types of porous composite
hydrogels. Cell attachment was observed from counting the floating cells in the media
after initial cell seeding for 8 h. (A) Percent attachment of BMSCs in each type of
hydrogels. Values expressed are mean (n = 3) ± S.D. (B) CellTiter Blue® metabolic
activity assay of BMSCs culture in different types of hydrogels at different time points.
Values expressed are mean (n=3) ± S.D. of RFU that were normalized against PAH for
each time point. Samples were compared using paired equal variance student t-test, **p <
0.005.
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Figure 1.8. Scanning electronic micrographs of cell inside the hydrogels, showing the
cell morphology in porous composite hydrogel (A) PAH and (B) TMV-PAH. Scale bar =
10 microns.
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1.2.3 Osteogenic differentiation of BMSCs in 3D virus-incorporated hydrogels
For the application point of view, our previous works provided a solid background of
bone tissue development improved by TMV and other plant viruses. The 2D studies
demonstrated that substrates coated with plant viruses supported BMSCs growth and
accelerated cell differentiation.32 TMV decorated with phosphates caused an increased
calcium sequestration and higher expression levels of genes related to osteogenesis.16
Plus, the concept of diversity in differentiation ability of BMSCs has been well
established in the past years. In particular, their osteogenic differentiation potential has
become one of the most widely studied topics in bone regeneration. Large extent of
research has shown promising results when using osteoblasts differentiated from BMSCs
in bone regenerative processes.43, 44 The differentiation studies in our 3D devices were
directed to the osteogenic lineage of BMSCs in osteogenic supplemented media. The
differentiation of seeded BMSCs toward the osteogenic lineage was explored by
analyzing several cell differentiation markers.
First, the activity of alkaline phosphatase (ALP), an early osteoblastic marker that
reflects not only the stage of cell differentiation but also represents the percentage of
committed osteoprogenitor cells, was evaluated. The activity of this enzyme increases
during synthesis of the extracellular matrix, which corresponds to the beginning of cell
differentiation.45, 46 The ALP activity was initially assessed at days 3, 7, and 14 upon
culturing in the osteogenic medium (Figure 1.9A). Low levels of enzyme activity were
detected for all three samples for day 3 cultures, followed by marked increases in ALP
activities on days 7 and 14. The incorporation of the virus did not appear to hinder the
differentiation potential as the same elevation trends of overall ALP activities were
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Figure 1.9. Osteogenesis assays of BMSC in porous composite hydrogels. (A) ALP
activity assay was performed on day 3, 7, and day 14 of osteogenic culture. Values
expressed are mean (n=3) ± S.D., ≠/*paired equal variance Student t-test, p < 0.05. (B)
Calcium deposition quantified by ICP-OES on day 6 after background subtraction from
control samples with no cells. Values expressed are mean (n=3) ± SEM, *paired equal
variance Student t-test, p < 0.05. (C) Thin sections of hydrogels stained with Alizarin red
on day 14 cultures, scale bar = 2 mm.
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measured among the three groups from day 3 to day 14. Interestingly, RGD-PAH seemed
to accelerate an early osteogenesis of BMSCs as the ALP activity was significantly
higher among three samples on day 3. However, on day 7, the unexpected higher level of
ALP activity was observed for PAH compared to the virus-functionalized PAH. Based on
the comparison of the three matrices cultures, ALP activity was found to be the same
trend, showing an increase in the enzyme activity from day 3 to day 14 in all three
hydrogels as the development of bone tissue. Essentially, the incorporation of TMVRGD1 was shown to promote an early stage differentiation by significantly elevated ALP
activity observed on day 3 compared to those from PAH and TMV-PAH.
Although the ALP activity’s result from day 7 showed otherwise, the following
calcification analysis from ICP-OES showed the significant increase in mineralization in
RGD-PAH that was already occurred on day 6. Calcium deposition in three types of
hydrogels with BMSC osteogenic culture was quantified by ICP-OES (Figure 1.9B). The
average amounts of calcium deposited in both TMV-PAH and RGD-PAH after
background subtraction from control samples without cells were higher than in PAH
(Figure 1.9B). All three types of hydrogels with BMSCs osteogenic culture were stained
with Alizarin red giving intense red color (Figure 1.9C). Although calcium is used as a
cross-linking agent, PAH without cells stained lighter pink with the dye (see Appendix
B). A higher calcium level of osteogenic culture in TMV- and RGD-PAH could be a
consequence of the high calcium binding affinity of TMV.47, 48 This issue was taken into
account as the calcium produced by differentiating cells could be sequestered more in
TMV- and RGD-PAH. The high level of calcium accumulation indicated an enhanced
bone formation.
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Hydroxyapatite is a major mineral component of calcified tissue (bone and teeth).
Its composition is a crystalline form of calcium (Ca) and phosphorus (P), with the
formula Ca10(PO4)6(OH)2.49 To further confirm the presence of Ca and P in the stem cell
impregnated hydrogels, elemental analysis for the two samples were determined. The
results indicate deposition of calcium phosphate around the cell areas with higher Ca
levels detected for both PAH with and without TMV (Table 1.2). In PAH, the amount of
P was less as nondetected in the scaffold.
As BMSCs undergo the phase of the maturation and ECM remodeling,
osteocalcin is considered as the most specific marker of mature osteoblasts. Osteocalcin
is a calcium binding protein, gets accumulated in mineralized bone, and binds actively to
hydroxyapatite crystals promoting bone crystal growth.31 It actively controls the process
of ossification, ECM remodeling, and maturation. We observed this biomarker via
immunostaining, which exhibited the intense localization of osteocalcin within 13 days of
osteogenic induction culture in all three composite hydrogels. Figure 1.10 illustrated the
accumulation of osteocalcin after day 10 (PAH) and day 13 (TMV-PAH and RGD-PAH)
and confirmed that virus incorporation into 3D matrices did not impair the differentiation
potential of BMSC into osteogenic lineage.
Also, the results from calcium deposition studies including Alizarin red staining,
quantification of calcium deposited in the hydrogels by ICP-OES, and elemental analysis
using EDX confirmed that differentiated BMSCs underwent mineralization process in
composite porous hydrogels under BMP-2 free osteogenic induction. However, unlike
what others have reported on similar work with RGD peptide modification in hydrogel
systems,50 the results herein did not show a dramatic increase in ALP activity on early
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Table 1.2. Mineralization assay by EDX (Elemental analysis) of BMSC osteogenic
culture on day 17 in PAH, TMV-PAH, and RGD-PAH showed peak intensity for calcium
and phosphorous around the cell in all three samples.

PAH

TMV-PAH

RGD-PAH

Elements

Around cells

Scaffold

P

9.55

N/D*

Ca

69.15

56.75

P

15.45

17.05

Ca

283.6

160.65

P

23.00

18.00

Ca

217.85

148.75

*Not detected
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Figure 1.10. Confocal images of differentiated BMSCs in 3D composite hydrogels
stained for nucleus (blue), actin (green) and osteocalcin (red). Scale bar = 50 microns.
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BMSC differentiation when more biofunctionality was added through TMV-RGD. The
possible explanation could be the limited concentration of RGD peptide that was exposed
in the hydrogel due to the fairly low percentage (0.1%) of TMV-RGD incorporated in the
hydrogel. Yang et al. demonstrated that RGD can promote ALP and osteocalcin
production of BMSCs, however, in a dose-dependent manner, in peptide covalently
incorporated poly(ethylene glycol) diacrylate hydrogel.51 Therefore, the optimum
concentration of TMV and TMVRGD can be further explored to improve the BMSC
osteogenesis in this system
Moving forward in a tissue engineering direction, a near future study will be
focusing on the improvement of hydrogel synthesis regarding uniformity in size and
shape of hydrogels, essentially for further in vivo studies, including biocompatibility and
in vivo bone formation. Besides, with the unique nature of TMV, we can potentially bring
other specific ligands to 3D porous composite hydrogel with multivalency directing the
stem cell differentiation in other lineages.16 In addition, there are opportunities to develop
this virus-based combinatorial hydrogel functionalization for better therapeutic outcome,
for example, conjugation of growth factors and other small molecules to promote stem
cell differentiation or vascularization, as well as endogenous stem cell recruitment
chemokines to accelerate wound healing process.52, 53

1.3 CONCLUSION
We have successfully synthesized the alginate-based porous composite hydrogels
functionalized with biomacromolecules and demonstrated their advantage as vehicles to
support the 3D stem cell culture and differentiation. We have shown that TMV surface
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can be accessible in 3D porous hydrogels as shown by significant improvement in cell
attachment after functionalization by TMV-RGD1. Moreover, the incorporation of TMV
and its RGD mutant can facilitate bone differentiation of BMSCs. This study is
considered a proof-of-concept for utilizing virus particle to display functionalities onto
the 3D alginate porous hydrogel. Together with further biocompatibility and bone
formation studies in vivo, this system could be even more applicable for tissue
engineering biocompatible matrix. This attractive approach could not only allow for the
localization, delivery, and differentiation of stem cells but also contribute the advantage
of simplicity in matrix modifications.

1.4 EXPERIMENTAL SECTION
All chemicals were obtained from commercial suppliers and used as received unless
otherwise noted. Wild-type TMV (TMV) and its RGD-mutant (TMV-RGD1) were
isolated from infected tobacco leaves following previously established protocols.23

1.4.1 Synthesis of virus-incorporated porous alginate hydrogels
The synthesis of gas template solid foam was based on the methodology reported by
Barbetta et al.28 Briefly, 5% w/v low viscosity sodium-alginate (Protanal® LF 10/60 FT,
30-60 mPas for 1%, kindly provided by FMC Biopolymer UK Ltd.) was dissolved in 2%
w/v sodium bicarbonate (NaHCO3) and 4% w/v pluronic F108 solution. Molar equivalent
of citric acid with respect to NaHCO3 was added to the mixture while stirring. Stirring
was continued for 15 min to allow CO2 to fully develop. Afterward, the foamy alginate
solution was flash frozen in liquid nitrogen and freeze-dried. The resulting solid foam
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was soaked in 2 M of CaCl2 for 24 h to induce the formation of the calcium-based
physical gel and then dialyzed against large volume of 0.1 M CaCl2. Finally, the solid
foam was freeze-dried, resulting in porous alginate hydrogel (PAH). For the TMV
modified PAH (TMV-PAH), or mutant TMV-RGD1 modified PAH (RGD-PAH), 0.1%
w/v of virus was added to the solution 10 min after adding citric acid. The mixture was
stirred for another 5 min.
TMV-PAH was de-crosslinked and dissolved in 0.5 M EDTA, and the solution
was analyzed under transmission electron microscopy (TEM) (Hitachi H-8000
microscope) on 300 mesh copper grids coated with carbon and stained with 2% uranyl
acetate. The absorbance at 260 nm was measured by UV-Vis spectroscopy to confirm the
concentration of TMV in de-crosslinked alginate solution.

1.4.2 Environmental scanning electron microscopy
Environmental scanning electron microscopy (ESEM) images and elemental analysis by
EDX were obtained by FEI Quanta 200 electron microscope. Freeze dried samples were
cut to about 2 × 2 × 2 mm3 cubes and mounted on aluminum stubs with carbon tape. For
ESEM, samples were observed under a low vacuum with 30 kV of electron acceleration,
a spot size of 4-6, and a 6-10 mm working distance. The same condition was used for
EDX except the work distance was fixed at 10 mm and at least 3 areas were analyzed.
Cell morphology in hydrogels was visualized by ESEM. Day 8 cultured hydrogel
samples were prepared following the biological preparation procedure for ESEM. In
brief, the samples were fixed in 2.5% glutaraldehyde in 0.1 M cacodylated buffer (pH
7.4) overnight at 4⁰C and post-fixed in 1% OsO4 in cacodylated buffer for 1 h at 4⁰C in
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dark. The samples, after being washed 3 times with cacodylated buffer, were frozen in
liquid N2 and lyophilized. The lyophilyzed samples were mounted on aluminum stubs
using a carbon tape.

1.4.3 Swelling property of PAH
Swelling property of PAH was determined by the final weight divided by the initial
weight of the hydrogel. The initial weights (2-3 mg) of freeze dried PAH and TMV-PAH
were recorded (µ0). Hydrogels were immersed in water, and then the weights after
hydration of hydrogels were recorded over time (µƒ). Surrounding water was drained and
blotted out with Whatman filter paper from hydrated hydrogels before weighing. The
study was continued for 4 weeks to observe the stability of the hydrogels. The swelling
ratio was defined as μƒ/μ0.

1.4.4 TMV releasing profile
TMV releasing profile was observed for the stability of TMV-PAH. Fluorescently labeled
TMV (TMV-Fl) was prepared by carbodiimide coupling reaction (see Appendix C for the
MALDI-TOF analysis of the fluoresceinamine internal modification of wild-type TMV
and TMV-Fl emission spectrum) according to the reported protocol20 and incorporated in
alginate hydrogels as previously described. Firstly, the standard curve (Appendix C) of
fluorescent intensity from different concentration of TMV-Fl was generated. The reading
was measured at 490/530 nm (Ex/Em). Each TMV-PAH (3 × 3 × 2 mm3) was submersed
in 1 mL 100 mM CaCl2 Tris-buffered saline (TBS) pH 7.4. From each sample, 100 μL of
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buffer solution was collected and replaced by the same volume of fresh buffer at different
time points.

1.4.5 Mechanical testing
The mechanical properties of porous alginate hydrogels before and after the inclusion of
TMV or TMV-RGD1 were compared via unconfined compression testing. Disk-shaped
samples (3 mm height, 1.5 mm radius) of each material were maintained in TBS until the
time of testing. Each hydrated material sample was placed between flat platens of a
mechanical testing system (Bose Electroforce 3200 series instrument) and immediately
subjected to displacement-controlled compression of 0.45 mm (displacement rate of 1
mm min-1) without neither water submersion fixture nor water replacement during
compression. Sample deformation and load were continuously recorded (50 measurement
sec-1) by the system software (Wintest), and subsequently processed to generate true
stress versus strain curves. Material incremental moduli were calculated based on average
data linearization in two strain regions (0-0.05 and 0.1-0.15) to provide a basis for
assessing the effect of TMV or TMV-RGD1 inclusion on the mechanical properties of
PAH.

1.4.6 DSC and TGA tests
Modulated differential scanning calorimetry (MDSC) measurements on dry PAH, TMVPAH, and RGD-PAH were carried out using a TA Q2000-DSC thermal analyzer (TA
Instruments, New Castle, DE, USA). Hydrogel samples and TMV alone (5-10 mg, with
0.1 mg accuracy) were packed down and sealed in aluminum solid pans, and an empty
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pan was used as reference. The pans were heated at a scan rate of 3°C/min according the
following program: equilibrated at 0°C, modulated at ±1°C every 60 sec, kept isothermal
for 5 min, and then heated to 220°C. Reversible and non-reversible heat flow signals
were separated from the total heat flow signals. The peak melting temperature was
determined from the reversing heat flow signal.
Thermogravimetric analysis (TGA) was carried out using a SDT 2960
Simultaneous DTA-TGA thermogravimetric analyzer (TA Instrument). The sample was
heated from room temperature to 700°C at a rate of 5°C/min under Helium gas flow.
Prior to analysis, the samples were thoroughly dried in a vacuum for overnight.

1.4.7 Bone Marrow Stem Cells (BMSCs) isolation and culture
Primary BMSCs were isolated from the bone marrow of young adult 160-180 g male
Sprague-Dawley rats (Charles River Laboratories). The procedures were performed in
accordance with the guidelines for animal experimentation by the Institutional Animal
Care and Use Committee, School of Medicine, University of South Carolina. Cells were
maintained in complete primary media (Dulbecco’s Modified Eagle’s Medium (DMEM)
supplemented with 10% fetal bovine serum (FBS)), kept at 37°C in a CO2 incubator with
5% CO2 : 95% air and passaged no more than seven times after isolation.

1.4.8 Cell seeding and attachment studies
Lyophilized PAH, TMV-PAH, and RGD-PAH were cut to 3 × 3 × 2 mm3 cubes. In each
set of experiment, six hydrogels per type of sample were used for these studies.
Hydrogels were sterilized in 70% ethanol for 15 min, ethanol was drained on sterile filter
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paper and the hydrogels were further sterilized under UV-light for 60 min in laminar
airflow hood. Hydrogels were then saturated in complete primary media at 37°C for 60
min, blotted excess media with sterile filter paper, and placed in 12-well non-adhesive
plate (6 hydrogels in each well). BMSCs were harvested from 80% confluent culture
flask using 0.25% trypsin/EDTA for 5 min and counted and re-suspended in complete
primary media. 1.4 × 103 BMSCs were seeded per one volume of hydrogel. Rat BMSCs
loaded hydrogels were initially incubated with 200 μL of complete primary media in each
well to prevent hydrogels from drying out. After 6 h of an initial incubation, hydrogels
were completely submersed in 1 mL of complete primary media in each well. The
hydrogels seeded with rBMSCs were cultured at 37°C and 5% CO2.
Attachment percentages were determined for different types of hydrogels on day
1 after cell seeding by counting floating cells in each well with a hematocytometer. Three
separate experiments were carried out in this study.
Attachment percentage

total seeding cell number floating cell number
total seeding cell number

1.4.9 Cell viability
CellTiter-Blue® (CTB) cell viability assay (Promega) after day 8 and day 14 of culture
was performed for each type of hydrogel. The culture media in each well was replaced by
1 mL of pre-warmed media containing 10% CTB and incubated for 1 h at 37°C and 5%
CO2. The media containing CTB was used without cells as negative controls. The
measurement of the CTB product was taken at two time points. First, to detect the cells
that attached to the outer surface of hydrogel, the solution was collected and replaced
with 1 mL of culture media. The incubation was continued for another 2 h to allow
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diffusion of the fluorescent product from the inner part of hydrogel. After 2-hour
incubation, the media solution was collected again and replaced with 1 mL of culture
media in each well to continue cell culture. The 1:1 mixture of solution from first
collection and second collection was measured for fluorescence intensity at 560/590 nm
(Ex/Em) using SpectraMax M2 Multi-Mode microplate reader (Molecular Devices).
Also, three separate experiments were conducted with each type of sample, which
comprised of 6 hydrogels.

1.4.10 Osteogenic culture
After 1 day of cell seeding, complete primary media was replaced by osteogenic media
consisting of DMEM supplemented with 10% FBS, 10 mM sodium β-glycerol phosphate,
l-ascorbic acid (50 μg/mL), 10−2 μM dexamethasone, penicillin (100 units/mL),
streptomycin (100 μg/mL), and amphotericin B (1 μg/mL). The osteogenic media was
changed every 2 days. The culture was incubated at 37°C and 5% CO2.

1.4.11 Alkaline phosphatase (ALP) and mineralization assays
Alkaline phosphatase (ALP) activity was determined using pNPP (p-nitrophenyl
phosphate) assay (Sigma Diagnostics). After 3, 7 and 14 days, the hydrogels with cells
were pre-washed with TBS then incubated with pNPP solution at room temperature for
2.5 h. Absorbance was read using a M2 SpectraMax plate reader at 405 nm indicating
ALP activity levels. The enzyme activity was calculated from Beer-Lambert law as
follow,
V ( L)
D405nm (cm 1)
incubation time (min) enzyme ( g)

Enzyme activity ( moles/min/ g)
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where is the molar extinction coefficient (M-1 × cm-1). For p-nitrophenol,
1.78 × 104 M-1 × cm-1. OD405nm (cm-1) is the absorbance at 405 nm divided by the lightpath length (cm). V is the final assay volume (100 μL).
Alizarin Red S (ARS) staining for Ca2+ was performed on day 14 cultures. The
hydrogels with cells were washed 3 times with TBS and fixed in 10% buffered formalin
overnight and sliced into 1 mm thick samples. The sections were then stained with 0.1%
solution of ARS (Sigma-Aldrich) pH 4.1-4.5 for 30 min, washed with 1:1 xylene:acetone
solution and placed with toluene mounting solution on glass slides. Control experiments
without cells were conducted for PAH, TMV-PAH, and RGD-PAH.
Calcium concentrations were quantified using Varian 720-ES ICP-OES
(Inductively Coupled Plasma - Optical Emission Spectrometer) elemental analysis.
Standards were created using 0-0.4 mg/L calcium standard solutions. PAH, TMV-PAH
and RGD-PAH with similar size and weight were seeded with BMSCs and cultured with
osteogenic supplement media until day 6. Samples were washed with sterile Milli-Q
water and completely lysed with dissolving solution (0.1% HNO3, 0.01% TritonX-100, in
100 mM sodium citrate). The dissolved samples were diluted to fit the range of the
standard curve. Approximately 4 mL of each diluted sample was fed into the instrument
per run. The experiment was performed in triplicates. Control experiments without cells
were also performed for PAH, TMV-PAH, and RGD-PAH in the same manner.

1.4.12 Immunostaining
Immunostaining was performed to observe the presence of osteocalcin. rBMSCs culture
in PAH, TMV-PAH, and RGD-PAH were terminated after culturing 10 days for PAH
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and 13 days for TMV-PAH and RGD-PAH hydrogels in osteogenic media. Hydrogels
were washed three times with 100 mM cacodylated buffer and then fixed in 2.5%
glutaraldehyde in cacodylated buffer overnight. The fixed samples were then
permeablized for 15 min in TBST (0.05% Tween20) and blocked in 2% w/v bovine
serum albumin (BSA, Sigma–Aldrich) in TBS for 20 min with gentle agitation at room
temperature. After blocking, the hydrogels were incubated for 2 h with primary antibody
targeting the osteospecific protein osteocalcin (Santa Cruz Biotechnology). Secondary
antibody detection Alexa Fluor® 546 (Molecular Probes, Invitrogen) was used for
osteocalcin at 1:100 dilutions in blocking buffer for 1 h at room temperature. In the end,
the hydrogels were washed with TBS and counter-stained with DAPI (nuclear staining)
and FITC-Phalloidin (actin staining). Images of the stained samples were obtained using
Olympus IX81 with DSU confocal mode under 20x oil lens (NA = 0.85). Exposure times
were kept constant for all samples (500 ms for DAPI and phalloidin, 1000 ms for
osteocalcin).
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CHAPTER 2
IN VIVO COMPATIBILITY AND DEGRADABILITY OF TOBACCO MOSAIC VIRUS
INCORPORATED HYDROGELS AS SCAFFOLDS FOR TISSUE ENGINEERING
3.1 INTRODUCTION
3.1.1 Virus and virus-like nanoparticles in tissue engineering
Virus nanoparticles are now gaining great interest from different interdisciplinary fields
especially in material science as nanoscale building blocks. The major advantage of virus
nanoparticles is that they can easily be produced in gram quantities with high uniformity
in laboratory. Viral capsids can be in different sizes, shapes and arrangements. They are
exceptionally robust in that their surface modifications are amendable by genetic and/or
chemical approaches, thereby presenting different types of functionalities.54, 55 The use of
chemical ligands can be complemented by the genetic engineering of virus coat proteins
that offer multivalency of specific peptides.24, 56 Moreover, spatial display of signaling
molecules or peptides can be obtained at the nanometer scale leading to the
programmable designs for quantitative investigations of cell behaviors.57, 58 Among viral
nanoparticles, plant viruses are considered safer than human pathogen-derived viruses
such as adenovirus in terms of handling, processing, and downstream medicinal
applications.59 These properties make the plant viruses attractive tools for biomedical
applications including drug delivery and tissue engineering.60, 61
Our group had introduced the use of plant viruses as scaffolding materials to
probe cellular behaviors. Some of the previous publications focused on the enhanced
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bone regeneration from bone marrow stromal cells (BMSCs) using Tobacco mosaic virus
(TMV) and its mutants.16, 17, 25 Along the same line, our attempt has translated into a three
dimensional (3D) model using alginate, a well-known biologically inert natural polymer,
as the TMV-functionalized 3D hydrogel’s base-material. The 3D porous alginate
hydrogels (PAH) functionalized with wild-type TMV (TMV-PAH) and its RGD mutant
(RGD-PAH) have been developed. This proof-of–concept study indicated that the
integration of biofunctionality in 3D hydrogel could be simply achieved by the
incorporation of viral nanoparticles which carry the functional units therefore maintain
the ability to regulate cell behavior in the hydrogel environment. As shown in our study,
RGD-PAH gel had increased cell loading capacity with higher alkaline phosphatase
activity in early-stage osteogenesis of BMSCs in comparison to the control hydrogels
(PAH and TMV-PAH). We suggested that TMV can be used as a platform to provide a
variety of functionalities with nanoscale multivalency for tissue engineering
applications.37

2.1.2 In vivo toxicity and degradation of plant viruses in biomedicine
In vivo properties, especially any potential toxic effect needs to be taken into
account, when developing novel materials for biomedical applications. There have been
many studies that reported the in vivo characteristics including biodistribution and
toxicity of different types of viral nanoparticles used in biomedicine.62-67 For example,
spherical plant viruses, cowpea mosaic virus (CPMV) and cowpea chlorotic mottle virus
(CCMV), as well as filamentous bacteriophage M13, showed a broad biodistribution
throughout the body, albeit predominantly in the liver and the spleen.63-66 Blood clearance
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kinetics, biodistribution, and histopathology of rod-shaped TMV were also observed by
Wu et al, 2013. The study demonstrated that radio-iodinated TMV was accumulated
mostly in the spleen and the liver of BALB/c mice and U87MG tumor-bearing mice with
no overt toxicity. About 97% of TMV particles were eliminated from the blood
circulation by the reticulo-endothelial system (RES) within 40 minutes after intravenous
(IV) administration of ∼1 μg TMV per animal.67 Liver and spleen are parts of the RES
that play a critical role in removing antigens, including structured proteinaceous
nanoparticles, from circulation through mononuclear phagocyte system (MPS).62, 68, 69
Similarly, Steinmetz group studied pharmacokinetic properties of TMV in two different
shapes, 300 x 18 nm rods and 54 nm spheres. The rapid clearance of TMV was confirmed
in both shapes (rods had longer blood circulation) with blood and tissue biocompatibility.
Moreover, PEGylation of TMV could create the stealth layer shielding TMV from
recognition of RES leading to the longer circulation of the nanoparticle in blood stream.62
However, the immune responses for TMV were not addressed.62, 67 These studies
suggested that, even though, the animal’s physiologic system recognizes the viral
nanoparticles as foreign bodies, these do not necessarily reflect the systemic toxicity.
Antigenicity of TMV has been well established for more than 50 years.70, 71This
rod-like virus has been used extensively as a model system for studying various aspects
of virus-antibody interactions. TMV, when administered with adjuvant, gives very high
immunogenicity in vivo at doses as low as micrograms immunization per kilogram in
rabbits and mice.72-74 TMV has allowed immunologists to study and develop a system
that can enhance immune response to pathogenic antigens for vaccine applications.75, 76
Gilleland group constructed the genetically modified chimeric TMV by inserting
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sequences representing peptide of outer membrane protein F of Pseudomonas aeruginosa
between amino acids Ser154 and Gly155 of the TMV coat protein and observed the
immunoprotection to the bacteria in a mouse model of chronic pulmonary infection.77
Nevertheless, the systemic toxicity and immunogenicity of TMV as a functional material
in implanted polymeric hydrogels for tissue engineering in animals or human has not
been reported.
In our study, we focused on the toxicity of the hydrogels modified with TMV and
its mutant in animal model. We studied the potential of using the TMV-functionalized
PAH in stem cell bone tissue engineering in vivo by two means. First, the
biocompatibility and possible toxic effects of the subcutaneously implanted hydrogels
were investigated. The antigenicity of TMV in the hydrogel implant was also evaluated.
Second, the biodegradability of hydrogels was observed at the endpoint of the animal
study to further characterize this plant virus-hydrogel system regarding the suitability of
its application for tissue engineering.

3.2 RESULTS AND DISCUSSION
3.2.1 In vivo Biocompatibility of Plant Virus as Biomaterial for Tissue Engineering
Our recent discoveries suggested that TMV, as nanoparticle platform, offered a high
density of biofunctional ligands that were able to probe different cellular responses
including the induction of rapid bone differentiation in both 2D and 3D environments.16,
25, 36, 37, 55, 78

As reported in our previous paper,37 we have developed a 3D system of

TMV-functionalized macroporous alginate hydrogel that could facilitate bone
differentiation of BMSC in vitro. By incorporating RGD mutant of TMV to the hydrogel,
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cell loading capacity increased by at least 12% and the stem cells expressed greater
alkaline phosphatase activity after osteogenic induction. However, questions regarding
the in vivo toxicity of TMV-modified hydrogel were still unanswered.37 In this chapter,
we performed careful studies mainly focusing on the in vivo biocompatibility of the
hydrogels functionalized with wild-type TMV and its RGD mutant (Figure 2.1).
TMV is an RNA virus that typically infects plants and considered non-pathogenic
in human. Meanwhile, the virus could highly induce the adaptive immune response in
mammal.79, 80 Because of its well-known immunogenicity in mammal, we here evaluated
whether TMV, after being incorporated in the 3D biocompatible polymeric hydrogel
scaffold, could still cause serious toxicity and/or physical symptoms derived from
specific immune response in animal model. The animals were closely observed for the
entire experimental period. The surgical wound heeled within 1 week. Grossly, all mice
were normally active in eating, drinking, and grooming with no observable hair loss, skin
wounds on implanted sites, and aggressive behavior. The body weight of mice with
PAH, TMV-PAH, and RGD-PAH implanted were comparable to the mock group
(without any implant) as shown in Figure 2.2.
The blood samples from each group of mice in 2 and 4 post-operative weeks were
analyzed for total blood count. All animals had blood cell numbers counted in the normal
ranges (values shown under the bottom x-axis, Figure 2.3). The host inflammatory
responses after the surgery were evaluated by white blood count including total white
blood cell (WBC), lymphocyte (LYM), monocyte (MON), and neutrophil (NEU) counts.
In this study, these parameters in all mice were shown to fall in the normal range after
week 2 and continued to be normal until the end of experiment at week 4 (Figure 2.3).
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Figure 2.1. Schematic diagram depicted the synthetic procedure virus functionalized
composite hydrogel for implantation. Functionalization of composite hydrogels can be
achieved through direct mixing of virus solution to the foamy mixture of alginate. (A)
TMV particles after purification in 0.1 M potassium phosphate buffer was added and
dispersed into the foamy solution B. Scale bar is 200 nm (B) Alginate mixture comprised
of low viscosity alginate, Pluronic F108, sodium bicarbonate with an equivalent amount
of citric acid to generate gas templated foamy mixture. The mixture was molded, frozen
and lyophilized. The lyophilized sample was crosslinked with CaCl2, then lyophilized.
(C) The resulting hydrogel was 6.35 mm in diameter and 2 mm in height. (D) After
hydrated by sterile PBS overnight, the hydrogel was subcutaneously implanted at the
lower back of the experimental animal (circled).
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Figure 2.2. Animal growth rates were normal in all mice after implantation of different
types of hydrogels. The actual body weight at each time point was normalized with the
weight prior to the operation. The mouse weight was monitored along the experimental
period of 28 days. All the hydrogel implanted mice were healthy and growing normally
according to the mock control. Values expressed are means (n = 6, for day 2 – 14 and n =
3, for day 21 - 28) ± SD. Mock control data analyzed from 2 mocks on the first 2 weeks,
but 1 mock after week 2.
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Figure 2.3. Total blood analysis of mice implanted with porous composite hydrogels.
The hematology was essentially normal in all animals. The total blood counts were
performed at 2 time points (2 and 4 post-operative weeks). The histograms showed the
numbers of total white blood cells (WBC), lymphocyte (LYM), monocyte (MON), NEU
(neutrophil), red blood cell (RBC), hemoglobin (HGB), platelet (PLT), and mean platelet
volume (MPV). The normal range of each parameter for mice was indicated in the boxes
below the histograms. Values expressed are means (n = 6, for day 2 – 14 and n = 3, for
day 21 - 28) ± SD. Mock control data analyzed from 2 mocks on the first 2 weeks, but 1
mock after week 2.
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Other blood parameters that indicate animal health and significant loss of blood
such as red blood cell (RBC) and hemoglobin (HGB) were shown to be normal in all
animals as well. Even though platelet count (PLT) from every sample was lower than the
normal range, as well as the corresponding mean platelet volume (MPV) was shown to be
high, this result was consistent with the mock control in both time points (Figure 2.3).
The explanation could be an error caused by the automated blood counter instrument that
might have counted some aggregates of platelets from each blood sample showing less
numbers of PLT and increased number of MVP. The normal spleen weight between 3.0 ±
0.17 and 3.6 ± 0.14 g/kg of total body weight from each animal observed at the end of the
experiment indicated that there were no chronic and/or major inflammatory and toxicity
reactions in the RES that could cause the spleen enlargement in any group of animals
(Table 2.1).81
Histological sections of the explants were stained with H&E staining and
evaluated the infiltration of inflammatory cells, fibroblast, and new blood vessels into the
hydrogels. No significant differences were detected between each gel condition within
the same time point. Macrophages and lymphocytes were seen in the tissue around the
gel disks at both time points. At week 2, there were some inflammatory cells observed in
the peripheral area with 1.0 - 2.0 average score range, as well as the histological scores
from week 4 that fell between 1.0 - 1.7. Average scores of 0.3-1.0 indicated mild
inflammation observed in the center of the hydrogels from week 2, while they slightly
increased with no statistical significance (p > 0.05, ANOVA) to 1.0 - 2.0 at week 4. Very
few fibrosis was found in all explants (average score = 0.3) at week 2. However,
fibroblasts accumulated given statistically higher scores on week 4 (p < 0.05, ANOVA).
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Table 2.1. Average spleen weights of experimental mice at 8 week endpoint. Healthy
mice have normal spleen weight in the range between 0.085 - 0.112 g (calculated from 30
g of total body weight).33 Values expressed are means (n = 3) ± SD.

Mouse group

Spleen weight (g)

PAH

0.09±0.007

TMV-PAH

0.10±0.011

RGD-PAH

0.09±0.008

Mock

0.09±0.007
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New capillaries for which process required oxygenation of transplanted tissues82
were present in all types of hydrogels from both time-points at average score of 1.0 - 1.3
(Figure 2.4). Inflammatory cell infiltration, fibrosis and neovascularization indicated the
normal wound healing progress and emphasized that the macro-porous structure of these
hydrogels allowed cell invasion in vivo.27, 83
The fact that TMV causes humoral immune response in animals and is
consequently used as antigen expression system in vaccine has been extensively
reported.79, 80 Since in specific immune response a serious systemic reaction can be
induced sequentially from the antigen-antibody complex, we investigated the
immunogenicity of TMV-incorporated hydrogels supporting bone differentiation of stem
cell. From the ELISA assay, we found that TMV and its RGD mutant within the
hydrogels led to non-significant induction of specific anti-TMV Immunoglobulin G (IgG)
produced in mice. ELISA revealed lower anti-TMV antibody titers in mouse sera
collected from the animals implanted with TMV-PAH and RGD-PAH hydrogels in
comparison to the sera from mice that were challenged by native TMV solution (intramuscular injection) in the same amount of virus presented in the hydrogels (Figure 2.5).
This data suggested that there were only limited amount of TMV antigen released from
the hydrogels into the circulation system. The result also emphasized in vivo safety of this
virus-based combinatorial 3D material for tissue engineering.

3.2.2 In vivo Biodegradability of Hydrogels
Biodegradability of materials is one of the requirements for an ideal material applicable
to tissue engineering as it is essential to avoid an invasive implant removal procedure
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Figure 2.4. Histopathology analysis of hydrogel explants. Histological scoring of three
types of hydrogel explants showed similar degree of inflammation from both peripheral
and central areas, fibrosis, and vascularization within each time point of 2 and 4 weeks.
There were mild to moderate inflammation (average scores 1 - 2) from all the hydrogels.
The average fibroblast scores in all types of hydrogel slightly increased from week 2 to
week 4. Blood vessel formation was scored 1 on average in all explants from both time
points.
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Figure 2.5. Anti-TMV serum titers from mice implanted with different hydrogels. The
immune response to TMV in the implant materials was smaller in comparison to the
intramuscular injection of native TMV. Comparative serological analysis of the immune
response to each type of hydrogels was carried out by ELISA after 4 post-operative
weeks. Serum endpoint dilutions for anti-TMV immune response in mice implanted by
TMV-PAH and RGD-PAH were lower than ones challenged by single shot of native
TMV at the same amount presented in the hydrogels (11 µg). Values expressed are means
± SEM with each scatter plot represents each animal.
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after the new functional tissue has been developed in the patient. Moreover, the
degradation of the scaffold must closely follow the extracellular matrix (ECM) synthesis
and macroscopic tissue development. Thus, the rate of degradation of biomaterial
scaffolds is desired to correspond with the development of a type of tissue that they
replaced.84, 85 Here, we tested the hydrogel degradation by measuring the hydrogel size
reduced after 4 weeks of implantation and determining the number of hydrogel explants
that could be recovered after 8 weeks. Table 2.2 shows that out of 10 samples for each
group of hydrogel implant, 4, 6, and 6 of PAHs, TMV-PAHs, and RGD-PAHs,
respectively, were completely degraded within 8 post-operative weeks. Moreover, the
explants were significantly smaller than the starting hydrogels before implantation.
Figure 2.6 represents the photographs of the native hydrogel (Figure 2.6A) and the
different hydrogel explants (Figure 2.6B-D). The corresponding dot plot demonstrates the
volume reduction calculated from dimensions of each hydrogel explant. Approximately
half volume of hydrogels degraded during 4 post-operative weeks regardless of hydrogel
type (Figure 2.6 plots). The degradation of these hydrogels could be attributed to the
biodegradation of alginate hydrogel, the bulk forming materials used in the study. There
were two possible degradation events involving: 1) loss of calcium ion (crosslinker) by
diffusion into the surrounding medium and subsequent dissolution; and 2)
depolymerization of polymer backbone via β-elimination caused by alkaline
hydrolysis.86-88 Also, Pluronic F108 surfactant might have aided in facilitating faster
biodegradation of scaffold as reported by Nsereko and Amiji in which the chitosan alone
and chitosan with Pluronic surfactant were compared.89 In that report, they showed
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Table 2.2. Numbers of hydrogel implants recovered from sacrificed mice after 8 postoperative weeks.

Hydrogels

Recovery of Implant

PAH

60%

TMV-PAH

40%

RGD-PAH

40%
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Figure 2.6. In vivo degradability of porous composite hydrogels. Photographs illustrated
irregular shaped hydrogel explants with size reductions. (A) The hydrogel figure before
implant. (B-D) The images of typical explants of PAH, TMV-PAH, and RGD-PAH,
respectively. The bottom scattered plots indicated the volume reduction of each explant.
Values expressed are means (n = 3) ± SD.
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a significant increase in lysozyme degradation profile of the chitosan hydrogel with
Pluronic F108 and concluded that the higher porosity of hydrogel resulted from the
incorporation of surfactant.89 However, in our study, we did not observe differences in
the in vivo degradation of each hydrogel. The detailed degradation profiles of the
materials will need to be further explored.

3.3 CONCLUSION
TMV, as the plant virus nano-scaffolding material, is a versatile tool from natural source
for biomedical applications. We hereby conclude that TMV-functionalized porous
alginate hydrogel implant is biocompatible in mice. The antigenicity of TMV could be
suppressed when immobilized within hydrogels. The hydrogels were degraded in the
physiological condition, which is one of the important criteria when developing a
scaffold for tissue engineering. This virus-based hydrogel system can be further
developed to have a better-controlled biodegradation profile for a less-invasive route of
administration (injectable form). Overall, our result highlights the feasibility of
incorporating viral nanoparticles in biomaterials for in vivo regenerative medicine
applications.

3.4 EXPERIMENTAL SECTION
All chemicals were obtained from commercial suppliers and used as received unless
otherwise noted. Wild-type TMV (TMV) and its RGD mutant (TMV-RGD) were isolated
from infected tobacco leaves following previously established protocols.23

53

3.4.1 Synthesis of Virus-Incorporated Porous Alginate Hydrogels
The incorporation of TMV and its mutant (TMV-RGD) in porous alginate hydrogel was
based on previously reported methods.37 Briefly, 5% w/v low viscosity sodium alginate
(Protanal LF 10/60 FT, 30 − 60 mPas for 1%, kindly provided by FMC Biopolymer UK
Ltd.) was dissolved in 2% w/v sodium bicarbonate (NaHCO3) and 4% w/v pluronic F108
solution. Molar equivalent of citric acid with respect to NaHCO3 was added to the
mixture while stirring at 500 rpm using overhead stirrer, 115V. Stirring was continued for
15 min at room temperature to allow CO2 to fully develop. For the PAH modified with
TMV (TMV-PAH), or PAH modified with mutant TMV-RGD (RGD-PAH), 0.1% w/v of
virus was added to the solution 10 min after adding citric acid. The mixture was stirred
for another 5 min. Afterward, the foamy alginate solution was cast in 6.35 mm (0.25
inches) diameter, 2 mm thick aluminum mold and freeze-dried. The resulting solid foam
disc was soaked in 2 M of CaCl2 for 24 h to induce the formation of the calcium-based
physical gel and then dialyzed against large volume of 0.1 M CaCl2. Finally, the solid
foam was freeze-dried, resulting in porous alginate hydrogel (PAH) for implantation in
animal study (Figure 2.1).

3.4.2 Animals, Lethality Test and Animal Treatments
The procedures were performed in accordance with the guidelines for animal
experimentation by the Institutional Animal Care and Use Committee, School of
Medicine, University of South Carolina. NIH guidelines (or for non-U.S. residents
similar national regulations) for the care and use of laboratory animals (NIH Publication
#85 - 23 Rev. 1985) have been observed. Twelve-week-old male BALB/c mice were
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housed at 22 ± 2 °C with a 12-h light/ dark cycle and fed standard rodent chow and water
ad libitum. Mice were randomly assigned to experimental groups. For in vivo
biocompatibility tests, each group of animal (3 groups implanted by PAH, TMV-PAH,
and RGD-PAH) consisted of 6 mice excepted the positive control group for anti-TMV
antibody ELISA that consisted of 3 mice and the non-treatment control (mock) that
consisted of 2 mice. A total of 10 mice per each group were used to determine the
number of hydrogel explants that could be recovered after 8 post-operative weeks. Diskshaped hydrogels were implanted subcutaneously to assess biocompatibility. Briefly,
under anesthesia with 2-3% Isoflurane in oxygen, a small dorsal incision (~ 1 cm) was
made to create a subcutaneous pocket to place the implant along the back of the animal.
The skin was closed with surgical sutures. The animals were closely monitored (at least
once per week) for signs of distress or abnormal behaviors and measured body weight for
the entire experimental period. In the implanted groups, 3 animals in each group were
sacrificed at week 2 after implantation and another 3 animals were sacrificed at week 4 at
the end of experiment by cervical dislocation. The implanted animals and mocks were
bled via retro-orbital bleeding through the anti-coagulant coated glass capillaries every 2
weeks for blood count assay. The serum samples for ELISA were obtained after
centrifugation (2,000 g, 15 min, 4 °C) of blood samples collected from every animal just
before euthanization and stored at - 80 °C. The implant hydrogels were recovered after
the sacrifice of each animal. The size reduction of implanted hydrogels was measured on
the explants from week 4 using Vernier Caliper in terms of diameter and height with a
subsequent volume calculation. The implanted hydrogels with the surrounding tissues
were then preserved in 10% neutral buffered formalin individually in the tissue blocks for
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further paraffin embedding and histological assays. The liver, lung, brain, heart, and
spleen of all mice were isolated and weighted.

3.4.3 Antibody challenge for ELISA positive control
Administration of TMV in the positive control group was performed by intramuscular
injection of 11 µg TMV, which was calculated to match the average amount of TMV
presented in each implant hydrogel. TMV in phosphate-buffered saline (pH 7.4) were
sterile filtered before injecting into the animals.

3.4.4 Hematological assay
Complete Blood Count (CBC) was preceded right after each blood withdrawal. The
blood sample of 10 - 50 µL was transferred into 1 mL BD Microtainer Tube with
Dipotassium EDTA. Each tube was subjected to the automated blood counter machine,
model VetScan HM5 Hematology System. The numbers of total white blood cell (WBC),
neutrophil (NEU), monocyte (MON), lymphocyte (LYM), red blood cell (RBC),
hemoglobin (HGB), platelet (PLT), and mean platelet volume (MPV) were recorded and
analyzed according to the calibrated instrumental protocol, which indicated the normal
range of each parameter specifically for mice.

3.4.5 Paraffin Embedding and Histological Assays
The formalin preserved implanted hydrogels/tissues and organs of all mice were
embedded in paraffin blocks individually with proper orientations. Tissue sections (5
µm) were prepared and stained with hematoxylin and eosin (H&E). Based on the amount

56

of inflammatory cells (basically lymphocytes, neutrophils, macrophages, and so on)
observed within the center or peripheral areas of implants, the degree of tissue
inflammation was scored as 0, 1, 2, and 3 (normal; none, rarely seen; 1 to 5 per ×40
objective field, slightly increased; 5 to 20 per ×40 objective field, and obviously
increased; > 20 per ×40 objective field). Based on the degree of fibrous/connective
tissues and capillary blood vessels observed within the center or peripheral areas of
implants, the tissue fibrosis and vasculization were scored as 0, 1, 2 and 3 (none, rarely
seen; ≤ 2 vessels/ 40 field, slightly increased; 3 - 10/ ×40, and obviously increased; > 10
vessels/ × 40, respectively). Histological images were taken by using a Nikon microscope
and an Olympus digital camera.

3.4.6 Enzyme-Linked Immunosorbent Assay (ELISA)
ELISA was performed no later than 3 months after the sera were collected. In order to
coat wells with TMV as an antigen, high protein-binding conical bottom 96-well plate
was used. TMV (10 µg/mL, 100 mL) in Phosphate Buffer Saline (PBS) were added to the
microwells and incubated for 1 h at room temperature, followed by three PBS washes.
Blocking for non-specific binding was performed by adding 100 µL of 1% bovine serum
albumin (BSA) and incubating for 30 min at room temperature, followed by three PBS
washes. Binding was performed by adding 100 µL of serially diluted antiserum into
microwells and incubating for 1 h at room temperature, followed by thorough washes.
HRP conjugate anti-mouse IgG (Cayman Chemical Company) diluted at 1:20000 ratio
was added and incubated for 30 min at room temperature. Tetramethyl Benzidine (TMB
Plus, Amresco) and 1 M H2SO4 were added in sequence to the wells according to the
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manufacturer’s protocol, and the binding efficiency was monitored by measuring
absorbance at 450 nm.
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CHAPTER 3
BIOCOMPATIBILITY STUDY OF BMSCS INCORPORATED TMV ALGINATE HYDROGELS
3.1 INTRODUCTION
3.1.1 Bone marrow stromal cells in tissue engineering
Bone marrow stromal cells (BMSCs), also sometimes referred to as mesenchymal stem
cells (MSCs), are broadly used for regenerative medicine applications.90, 91 These cells
have two important innate abilities. First, MSCs can differentiate into distinctive endstage cell types, such as those that fabricate specific mesenchymal tissues including bone,
cartilage, muscle, bone marrow stroma, tendon/ligament, fat, dermis, and other
connective tissues. Second, MSCs, themselves, secrete a broad spectrum of bioactive
macromolecules that can aid restructuring microenvironments in sites of tissue injury.92
Although, numerous preclinical studies have established the therapeutic potential of
MSCs in tissue engineering and as cellular protein factory for delivery of cytokines and
anticancer agent,93 to date, MSC immunosuppressive and immunoprivilege properties
remain controversial.94-97 Most of the evidence for MSC immunoprivilege and
immunosuppression has been obtained using adaptations of the lymphocyte
transformation assays (LTA) and mixed lymphocyte reaction (MLR), respectively. The
reliability and sensitivity of these assays is dependent upon the optimization of the assay
conditions, and different conditions have yielded conflicting outcomes in some
instances.98 There were some studies reported that MSCs may also behave as
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nonprofessional antigen-presenting cells (APCs).99, 100 An enhancement of lymphocyte
proliferation was sometimes seen with MSCs co-cultured.100

3.1.2 Virus-functionalized alginate hydrogel scaffolds
In Chapter 1, we have shown that the porous alginate hydrogels (PAH) could be
functionalized with tobacco mosaic virus (TMV) and demonstrated their advantage as
vehicles to support the 3D stem cell culture and differentiation. TMV, as the plant virus
nano-scaffolding material, is a versatile tool from natural source for biomedical
applications. In summary, the 3D porous alginate hydrogels (PAH) functionalized with
wild-type TMV (TMV-PAH) and its RGD mutant (RGD-PAH) were developed. We have
also emphasized that TMV surface can be accessible in 3D porous hydrogels as shown by
significant improvement in cell attachment after functionalization by cell binding motif,
RGD, via the mutation of TMV. Moreover, the incorporation of TMV and its RGD
mutant can facilitate bone differentiation of BMSCs. We reported (Chapter 2) that the
virus is biocompatible in the form of porous hydrogel implant using BALB/c mice as the
in vivo study model. The antigenicity of virus could be suppressed when immobilized and
slowly released from the bulk hydrogels. The hydrogels were degraded in the
physiological condition, which is one of the important criteria when developing a
scaffold for tissue engineering.
Here, we further characterized the in vivo properties of this hydrogel system by
focusing on the potential of using the TMV-functionalized PAH to incorporate BMSCs in
bone tissue engineering. The key objective of this study was to rule out the
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biocompatibility and possible toxic effects of the subcutaneously implanted hydrogels
when BMSCs were co-delivered with serum-free osteogenic supplemented media.

3.2 RESULTS AND DISCUSSION
3.2.1 Ex vivo bone marrow stromal cells loading
To investigate the potentiality of the virus-functionalized hydrogel in stem cell bone
tissue engineering application, isolated murine BMSCs from the host strain (BALB/c
mouse) were loaded in the hydrogel and primarily induced with non-BMP2 osteogenic
induction media before implant. The isolated BMSCs were cultured and expanded in
vitro. After cells were seeded in the hydrogels, the in vitro parallel study of call metabolic
activity showed that cells were viable in the hydrogels (Figure 3.1). Moreover, RGD
mutant of TMV embedded in the hydrogels clearly enhanced cell adhesion. The results
were consistent with the in vitro report in which significantly higher metabolic activity of
the BMSCs, isolated from Sprague-Dawley rats, in RGD-TMV functionalized hydrogel
was shown (Chapter 1).

3.2.2 Immunogenicity of virus in the hydrogel seeded with osteogenic induced BMSCs
Previously in Chapter 2, we demonstrated the remarkable decrease in immunogenicity of
TMV incorporated in the hydrogel in BALB/c mice implanted with the materials alone
without cells seeded. However, the results did not rule out that immune responses may be
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Figure 3.1. CellTiter Blue metabolic activity assay of mBMSCs cultured in different
types of hydrogels at different time points, in vitro. Values expressed are mean (n = 3) ±
SD of RFU that were normalized against PAH for each time point. **p < 0.005, student t
test.
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elicited in the presence of 1) co-delivered cells or 2) other biological entities due to an
adjuvant effect. Although MSCs have been widely reported to have immunomodulatory
capacity and an immunoprivileged status,101-103 for example, strong evidence suggested a
delay in B cell maturation and antibody production by MSCs in mice104, 105 and human
cell culture,106, 107 their interaction in vivo is still not well known.108 Here, we studied the
immune response to TMV particles in TMV-PAH and RGD-PAH seeded with mouse
BMSCs and saturated with osteogenic induction media. The hydrogels were first soaked
in the osteogenic induction media before cell loading. Then the cell-loaded scaffolds
were implanted under the skin of the animal. The animals implanted with bare hydrogels
(hydrated with PBS), without cells and osteogenic media, were used as control groups for
all type of hydrogels. The blood samples collected at the end of the experiment (8 postimplantation weeks) were subjected to ELISA assay. Figure 3.2 showed no differences in
anti-TMV titers comparing the controls (no cells) and the hydrogels seeded with BMSCs
in osteogenic media. Moreover, regardless of co-delivered cells and media supplements,
the ELISA showed negligible immune responses to TMV and TMV-RGD imbedded in
the hydrogels. Despite the differences in serum collection time points, this data was
consistent with the previous experiment reported in Chapter 2 (sera collected at week 4).
Therefore, the result here confirmed that the release of TMV particles happened very
slowly over time at the dose that could not elicit a significant immune response.
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Figure 3.2. Anti-TMV serum titers from mice implanted with different hydrogels seeded
with BMSCs. Comparative serological analysis of the immune response to the hydrogels
co-delivered with BMSCs and the blank hydrogels was carried out by ELISA after 8
post-operative weeks. Serum endpoint dilutions for anti-TMV immune response in mice
implanted by TMV-PAH and RGD-PAH with osteogenic-induced BMSCs were very low
with no statistical significances in comparison to the response elicited by the hydrogel
alone. Values expressed are means ± SEM.
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3.2.3 Histological study
Histological sections of the explants were stained with H&E staining and evaluated the
infiltration of inflammatory cells, fibroblast, new blood vessels, and tissue/cell growth in
the hydrogels after 8 weeks. For every parameter, no significant differences were
detected between each type of hydrogel implant, PAH, TMV-PAH, and RGD-PAH,
seeded with BMSCs ex vivo. The average histological scores revealed that there were
mild to moderate inflammatory cells, fibroblast, and neovascularization at the
implantation site (Figure 3.3). However, very rare foam cells were observed within some
of the PAH explants, and none were found in TMV-PAH and RGD-PAH (Figure 3.3). It
has also been observed that there were few cell growths in the hydrogels possibly from ex
vivo seeded BMSCs; however, no substantial difference in the degree of cell growths
were observed among different hydrogel types. This result was inconsistent with the
study of cell adhesion study in vitro, which RGD-PAH could attract more cells into the
scaffold. This contrary could be justified as following. First, the vascular networks in
subcutaneous pocket/tissue are too poor in their natural state to allow the growth and
function of tissue graft.109 Second, the time of implantation was much longer than the
incubation time of in vitro study. The new extracellular matrix might be generated by the
physiological system through the wound healing events in animal body, and overcame
the influence from the implant material (RGD-PAH) in cell recruitment. Third, the
release of TMV particles due to the degradation of implant materials led to the loss of
scaffold functionality over time (Chapter 2). Moreover, the same set of histopathological
parameters was assessed comparing between the hydrogels with and without BMSCs. In
Figure 3.4, PAH and RGD-PAH showed no statistical differences in terms of
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Figure 3.3. Histological score given to hydrogel explants of ex vivo BMSC-loaded hydrogels compared implant cell growth,
peripheral inflammation, central inflammation, implant foam cell, fibroblast, and vascularization on PAH, TMV-PAH, and RGDPAH. Each plot represents the response from each animal with mean ± SD shown as a bar.
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Figure 3.4. For each type of hydrogel implant, histological score compared implant cell growth, peripheral inflammation, central
inflammation, implant foam cell, fibroblast, and vascularization on BMSC-loaded and naked implants. Each plot represents the
response from each animal with mean ± SD shown as a bar. Grey bars are for the scaffolds without cells. Black bars are for the
scaffolds with cells.

inflammations (both peripheral and central), implant foam cells, and vascularization
when comparing the blank scaffolds with the cell-seeded scaffolds. To our surprise, bare
TMV-PAH induced higher central inflammation and foam cells than the scaffold with codelivered cells. However, only one animal was used for the control TMV-PAH implant
here. To further test for statistical importance of this data, the animal number should be
increased.
Some studies suggested that MSCs have antifibrotic properties. Moodley et al.
reported that locally administered human umbilical cord MSCs reduced fibrosis of
bleomycin-induced lung injury in mice by decreasing collagen concentration at the
injured site.110 Leung et al. showed that the presence of MSCs can suppress abnormal
deposition of collagen I in the nucleus pulposus of intervertebral disc degeneration
rabbits, modulating profibrotic mediators MMP12 and HSP47, thus reducing collagen
aggregation and maintaining proper fibrillar properties and function.111 Here, only the
RGD-PAH implants exhibited the significant suppression of fibrosis when BMSCs were
present. There were no differences in fibrosis between the blank hydrogels and the
hydrogels seeded with BMSCs for PAH and TMV-PAH implants. Likewise, the presence
of BMSCs caused no differences in vascularization in any types of implants. The cell
growths in the cell-loaded implants were compared with the blank implants among each
hydrogel type. To our surprise, RGD-PAH showed distinct result to other types of
hydrogels. The RGD-PAH without pre-loaded BMSCs exhibited comparable/slightly
higher implant cell growth than the hydrogel with initial cell seeding. The possibility
could be that the available RGD peptide presented in blank RGD-PAH recruited MSCs
that travel through the peripheral blood112 at the early stage implantation.
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3.3 CONCLUSION
The TMV incorporated porous alginate hydrogel scaffolds were evidenced for the
biocompatiblity as ex vivo 3D supports for BMSCs and as in vivo cell delivery and tissue
development platforms. The cell-loaded implants caused insignificant changes in the
immunogenicity of TMV particles. Overall, mild to moderate inflammatory responses
were observed due to the injury triggered by normal wound healing and implantation of
foreign materials with no major differences in degrees of inflammation between the
BMSC seeded hydrogel and the control in both virus-functionalized hydrogels and PAH
alone. Hence, this virus functionalized hydrogel system is considered a promising
candidate as safe and easy incorporating biofunctional material well-suited for stem cell
delivery and tissue regeneration. This study is one of the underlying platforms for the
development of viral nanoparticle based biomaterials in tissue engineering and
regenerative medicine.

3.4 EXPERIMENTAL SECTION
All chemicals were obtained from commercial suppliers and used as received unless
otherwise noted. Wild-type TMV (TMV) and its RGD mutant (TMV-RGD) were isolated
from infected tobacco leaves following previously established protocols.23
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3.4.1 Synthesis of Virus-Incorporated Porous Alginate Hydrogels
The incorporation of TMV and its mutant (TMV-RGD) in porous alginate hydrogel was
based on previously reported methods.37 Briefly, 5% w/v low viscosity sodium alginate
(Protanal LF 10/60 FT, 30−60 mPas for 1%, kindly provided by FMC Biopolymer UK
Ltd.) was dissolved in 2% w/v sodium bicarbonate (NaHCO3) and 4% w/v pluronic F108
solution. Molar equivalent of citric acid with respect to NaHCO3 was added to the
mixture while stirring at 500 rpm using overhead stirrer, 115V. Stirring was continued for
15 min at room temperature to allow CO2 to fully develop. For the PAH modified with
TMV (TMV-PAH), or PAH modified with mutant TMV-RGD (RGD-PAH), 0.1% w/v of
virus was added to the solution 10 min after adding citric acid. The mixture was stirred
for another 5 min. Afterward, the foamy alginate solution was cast in 6.35 mm (0.25
inches) diameter, 2 mm thick aluminum mold and freeze-dried. The resulting solid foam
disc was soaked in 2 M of CaCl2 for 24 h to induce the formation of the calcium-based
physical gel and then dialyzed against large volume of 0.1 M CaCl2. Finally, the solid
foam was freeze-dried, resulting in porous alginate hydrogel (PAH) for implantation in
animal study.

3.4.2 Bone Marrow Stem Cells (BMSCs) Isolation and in vitro Expansion
Primary BMSCs were isolated from the bone marrow of young adult male BALB/c mice.
The procedures were performed in accordance with the guidelines for animal
experimentation by the Institutional Animal Care and Use Committee, School of
Medicine, University of South Carolina. Cells were maintained in complete primary
media (Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 20% fetal
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bovine serum (FBS)), kept at 37 °C in a 5% CO2 incubator and passaged no more than
six times after isolation.

3.4.3 Cell Seeding and in vitro Cell Viability
For each experimental group of animals, 4 hydrogels of PAH, 3 hydrogels of TMV-PAH
and 2 hydrogels of RGD-PAH were prepared for ex vivo cell seeding. All hydrogels were
sterilized in 70% ethanol for 15 min, ethanol was drained on sterile filter paper and the
hydrogels were further sterilized under UV-light for 60 min in laminar airflow hood. For
experimental group, hydrogels were then saturated in serum-free osteogenic media at 37
°C for 60 min, blotted excess media with sterile filter paper, and placed in 12-well
nonadhesive plate (six hydrogels in each well). The control hydrogels (no cells) were
saturated with sterile PBS instead of osteogenic supplemented media. Serum-free
osteogenic media contained high-glucose DMEM supplemented with 10 mM sodium βglycerol phosphate, L-ascorbic acid (50 μg/mL), 10−2 μM dexamethasone, 1 ITS, FGF
(1 ng/mL), TGFβ (1 ng/mL), EGF (1 ng/mL), penicillin (100 units/mL), streptomycin
(100 μg/mL), and amphotericin B (1 μg/mL). BMSCs were harvested from 80%
confluent culture flask using 0.25% trypsin/EDTA for 5 min and counted and
resuspended in complete primary media. A total of 30 × 103 BMSCs were seeded per one
volume (cm3) of hydrogel. BMSCs loaded hydrogels were initially incubated with 100
μL of serum-free osteogenic media in each well to prevent hydrogels from drying out.
After 6 h of an initial incubation, hydrogels were completely submersed in 1 mL of
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serum-free osteogenic media in each well. 12 h after cell seeding, cell loaded hydrogels
were then implanted to the animals.
For the in vitro cell viability assay, the hydrogels were prepared and seeded with
mouse BMSCs by the same procedure with the implant hydrogels. The hydrogels seeded
with BMSCs were cultured at 37 °C and 5% CO2. CellTiter-Blue (CTB) cell viability
assay (Promega) after days 2 and 6 of culture was performed for each type of hydrogel.
The culture media in each well was replaced by 1 mL of prewarmed media containing
10% CTB and incubated for 1 h at 37 °C and 5% CO2. The media containing CTB was
used without cells as negative controls. The measurement of the CTB product was taken
at two time points. First, to detect the cells that attached to the outer surface of hydrogel,
the solution was collected and replaced with 1 mL of culture media. The incubation was
continued for another 2 h to allow diffusion of the fluorescent product from the inner part
of hydrogel. After 2 h incubation, the media solution was collected again and replaced
with 1 mL of culture media in each well to continue cell culture. The 1:1 mixture of
solution from first collection and second collection was measured for fluorescence
intensity at 560/590 nm (Ex/Em) using SpectraMax M2 Multi-Mode microplate reader
(Molecular Devices). Also, 3 separate experiments were conducted with each type of
sample, which is comprised of 4 hydrogels.

3.4.4 Animals, Lethality Test and Animal Treatments
The procedures were performed in accordance with the guidelines for animal
experimentation by the Institutional Animal Care and Use Committee, School of
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Medicine, University of South Carolina. NIH guidelines (or for non-U.S. residents
similar national regulations) for the care and use of laboratory animals (NIH Publication
#85 - 23 Rev. 1985) have been observed. Twelve-week-old male BALB/c mice were
housed at 22 ± 2 °C with a 12-h light/ dark cycle and fed standard rodent chow and water
ad libitum. Mice were randomly assigned to experimental groups. Each group of animal
(3 groups implanted by PAH, TMV-PAH, and RGD-PAH) consisted of 6 mice. Diskshaped hydrogels were implanted subcutaneously. Briefly, under anesthesia with 2 - 3%
Isoflurane in oxygen, a small dorsal incision (~ 1 cm) was made to create a subcutaneous
pocket to place the implant along the back of the animal. The skin was closed with
surgical sutures. The animals were closely monitored (at least once per week) for signs of
distress or abnormal behaviors and measured body weight for the entire experimental
period. All animals were sacrificed at week 8 after implantation by cervical dislocation.
The serum samples for ELISA were obtained after centrifugation (2,000 g, 15 min, 4 °C)
of blood samples collected from every animal just before euthanization and stored at -80
°C. The implant hydrogels were recovered after the sacrifice of each animal. The
implanted hydrogels with the surrounding tissues were then preserved in 10% neutral
buffered formalin individually in the tissue blocks for further paraffin embedding and
histological assays. The liver, lung, brain, heart, and spleen of all mice were isolated and
weighted.

3.4.5 Paraffin Embedding and Histological Assays
The formalin preserved implanted hydrogels/tissues and organs of all mice were
embedded in paraffin blocks individually with proper orientations. Tissue sections (5
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µm) were prepared and stained with hematoxylin and eosin (H&E). Based on the amount
of inflammatory cells (basically lymphocytes, neutrophils, macrophages, and so on)
observed within the center or peripheral areas of implants, the degree of tissue
inflammation were scored as 0, 1, 2, and 3 (normal; none, rarely seen; 1 to 5 per × 40
objective field, slightly increased; 5 to 20 per ×40 objective field, and obviously
increased; > 20 per × 40 objective field). Implant cell growth and foam cells were also
scored with the criteria applied to inflammatory cells. Based on the degree of
fibrous/connective tissues and capillary blood vessels observed within the center or
peripheral areas of implants, the tissue fibrosis and vasculization were scored as 0, 1, 2
and 3 (none, rarely seen; ≤ 2 vessels/

40 field, slightly increased; 3-10/ × 40, and

obviously increased; > 10 vessels/ × 40, respectively). Histological images were taken by
using a Nikon microscope and an Olympus digital camera.

3.4.6 Enzyme-Linked Immunosorbent Assay (ELISA)
ELISA was performed no later than 3 months after the sera were collected. In order to
coat wells with TMV as an antigen, high protein-binding conical bottom 96-well plate
was used. TMV (10 µg/mL, 100 mL) in Phosphate Buffer Saline (PBS) were added to the
microwells and incubated for 1 h at room temperature, followed by three PBS washes.
Blocking for non-specific binding was performed by adding 100 µL of 1% bovine serum
albumin (BSA) and incubating for 30 min at room temperature, followed by three PBS
washes. Binding was performed by adding 100 µL of serially diluted antiserum into
microwells and incubating for 1 h at room temperature, followed by thorough washes.
HRP conjugate anti-mouse IgG (Cayman Chemical Company) diluted at 1:20000 ratio
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was added and incubated for 30 min at room temperature. Tetramethyl Benzidine (TMB
Plus, Amresco) and 1 M H2SO4 were added in sequence to the wells according to the
manufacturer’s protocol, and the binding efficiency was monitored by measuring
absorbance at 450 nm.
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CHAPTER 4
BONE REGENERATION IN RATS WITH CRANIAL DEFECT BY IMPLANTATION OF TMV
FUNCTIONALIZED ALGINATE HYDROGEL SCAFFOLDS
4.1 INTRODUCTION
4.1.1 Rat cranial segmental bone defect model
There are extensive needs for clinical bone replacement from patients with bone loss after
resection of tumors, bone loss after trauma, and voids created as a result of fractures.
Even though bone has a good healing capacity compared to other tissues, the regeneration
potential is limited in the case of large defects such as after tumor resection, major
fractures, hip implant revision, or impaired healing capacity of the host.113, 114 In such
cases, the use of bone grafts, derivates, or bone substitutes are indicated to promote
healing and regeneration.114-116 Current clinical methods of treating skeletal defects are
autograft and allograft bone transplantation. Autograft bone (bone transplanted from one
part of the body to another in the same individual) provides an environment that bone
cells like to grow and to make bone tissue. However, the supply of autograft bone is
limited. Allograft bone (bone from one person to another including those from cadaveric
and living related) has slower rate of healing compared to autograft bone and the
possibility of disease transfer. Therefore, material scientists introduced the concept of
tissue engineering using biocompatible artificial materials that offer an unlimited supply
for treating bone defects. 113, 117
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The translation of many therapeutics, including pharmaceuticals, medical devices
and medical strategies, into clinics requires an animal testing. Despite ethical concerns
and efforts to develop alternatives to animal experimentation, standardized animal
models are crucial components in translational sciences and medical technology
development.118-121 For bone tissue engineering, a number of small animal models exist.
Many species have been used for animal models of bone defects, including mice, rats,
rabbits, dogs, pigs, sheep and goats, but much of the research has focused on rodent
models because of reproducibility, throughput and economic considerations. The rat
calvarium or cranium allows for a reproducible defect that can be generated quickly and
does not require fixation for stabilization of the skeleton, as is generally required with
femoral defects.122, 123 However, as an anatomical site experiencing less loading than long
bones, the functional testing of a bone regeneration strategy intended to withstand
biomechanical forces is not feasible in the calvarial defect.124 Thus, taking into
consideration the objective of the biomaterial or bone regeneration strategy, the rat
calvarial defect can serve as a rapid, high throughput method for in vivo evaluation of
bone regeneration. The rat cranial segmental bone defect is a versatile model allows for
evaluation of biomaterials and bone tissue engineering approaches within a reproducible,
non-load-bearing orthotopic.125 For critical defects, i.e. defects that would not fully heal
spontaneously, or even to accelerate or guide the repair process, the use of bioactive
scaffolding material could be of great advantage. Suitable materials can, in fact, fill the
cavity or stabilize the defects while exerting beneficial stimuli that promote cell activity
and proliferation.117
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4.1.2 TMV nanoparticle-functionalized porous alginate hydrogel
The goal of this study is to assess the potential for plant virus/polymer hydrogels as
materials capable of enhancing bone formation/regeneration. The hydrogel is composed
of Tobacco mosaic virus (TMV) as protein templates with a mixture of a natural hydrogel
forming polymer that is biocompatible and biodegradable, sodium alginate (sugar-based
polymer derived from algae/seaweed). Alginate has been well established as a hydrogel
forming polymer that is used extensively in biomedical applications. However, alginate
itself cannot guide cells towards bone differentiation, unless complex mixtures of protein
materials (i.e. growth factors, cell binding sequences) are incorporated. Therefore, we
rationalized that TMV can supplement the polymer backbone to promote bone formation.
There are two rationales for using the plant virus. One, the plant virus cannot infect
mammalian cells. Historically and at present, there have been no reports of TMV
infections in mammals. Even in the case that the plant virus was to enter the mammalian
cells, it does not have the proper material to replicate itself inside the mammalian cells.36,
126-128

The virus solution can further be purified to be pathogen-free by sterile filtration.

Second, a large number of functionalities (cell anchorage sites, growth factors) can be
placed on the virus at the nanometer scale.23, 24 The ability to place specific functional
groups (cell anchorage sites, growth factors) at nanometer scales within the hydrogel has
been an important direction for tissue engineering. 23, 24 23, 24 23, 24 23, 24 23, 24 23, 24 Currently,
the preparation of complex hydrogels is a tedious process that involves multiple steps to
position the cell anchorage sites and growth factors within the hydrogel. By incorporating
cell-binding ligands on the external surface of TMV, we have shown that TMV can act as
nanometer sized building blocks that the plant virus act as nanometer sized materials that
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can support mesenchymal stem cells and dramatically improve the transformation of cells
into bone-like cells in vitro.16, 17, 37 We did not observe any decrease in cell survival even
with very high doses of TMV. Additionally, from our previous studies reported in
Chapter 2 for biocompatibility (subcutaneous) of TMV and its mutant (TMV-RGD)
incorporated alginate hydrogel scaffold in mice, we did not observe any serious immune
responses in comparison with the control group (mice subcutaneously implanted with
alginate-alone scaffold). Therefore, the proposed hydrogel will possibly provide a new
way to prepare biomaterials for bone repairing applications.

4.2 RESULTS AND DISCUSSION
4.2.1 Surgical recovery of animals
The survival surgery of cranial bone defect creation with subsequently hydrogel
implantation was carried out. Mean surgery time was 10 minutes (SD = 4). One out of the
21 animals did not gain consciousness and died after the surgery. Animal’s weight was
measured immediately after the cranial defect survival surgery on each animal to monitor
post-surgery weight loss. Figure 4.1A showed that all rats lost less than 5% of its initial
weight measured before the operation. Blood loss during surgical procedure was also
estimated to be less than 1 mL in all rats. The animals were closely monitored within the
first 6 hours after and weighed every day for the first post-operative week and at least
once every consecutive week, continuously for the entire experimental period.
Postoperatively, the rats recovered quickly, gaining their baseline weight and returning to
routine activities such as grooming, eating and drinking in less than 48 hours. The
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Figure 4.1. Animal post-operative care and monitoring. (A) All experimental animals only lost less than 5% of their original weights
after the surgery. The dot plot represented each animal with mean shown as a bar (n = 6, for PAH and TMV-PAH and n = 7, for RGDPAH). (B) The rats recovered quickly, the surgical wound healed completely and the suture material fell off spontaneously within 2
weeks. (C) All rats maintained their normal growth rates for the entire experimental period. Values expressed are means (n = 6, for
PAH and TMV-PAH and n = 7, for RGD-PAH) ± SD.

surgical wound heeled within 1.5 weeks without post-surgical bleeding or wound
infection. The surgical suture fell off spontaneously from the surgical site after the wound
healed completely (Figure 4.1B). From gross observations after cranial defect operation
and implantation, all animals were normally active in eating, drinking, and grooming
with no observable hair loss and aggressive behavior. The growth rate was evaluated by
body weight of rats at each time point normalized with their original weight before
implantation with PAH, TMV-PAH, and RGD-PAH. Comparing to the normal growth
rate of Sprague Dawley rats.129 All experimental animals grew normally with no weight
loss as shown in Figure 4.1C.

4.2.2 Systemic inflammatory and immunogenic responses
Complete blood count was analyzed from whole blood samples from each group of rats at
every week for 4 weeks, and then every other week until termination after 10 postoperative weeks. Figure 4.2 and 4.3 showed different blood counts in normalization to the
initial numbers that were analyzed from whole blood collected from a 8-week old normal
Sprague Dawley rat. The host inflammatory responses after the surgery were evaluated
by white blood count including total white blood cell (WBC), lymphocyte (LYM),
monocyte (MON), and neutrophil (NEU) counts. Overall, all animals had slightly low
WBC, LYM, and NEU comparing to the normal rat. However, the comparison had no
statistical difference for each parameter in each time point except for PAH group. Rats
implanted with PAH had significant lower WBC at week 1, 3, 8, and 10, and LYM at
week 3 and 10 compared to normal rat (p < 0.01, multiple t-test). MON count from all
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Figure 4.2. White blood count analysis of all rats with bone substitute implants. The total
blood counts were monitored at 8 time points (day 4, week 1, 2, 3, 4, 6, 8 and 10, postoperatively). The histograms showed the numbers of total white blood cells (WBC),
Lymphocyte (LYM), Monocyte (MON), NEU (neutrophil) normalized with the values
measured from non-treated rat. Each bar indicated min to max with mean as the middle
horizontal bar (n = 6, for PAH and TMV-PAH and n = 7, for RGD-PAH) ± SD. From ttest analysis comparing control (non-treatment) and experimental value, the filled bars
represented statistical significance, p<0.05. Red dots represented outliers.

82

Figure 4.3. Hematology analysis of all rats with bone substitute implants. The total blood
counts were monitored at 8 time points (day 4, week 1, 2, 3, 4, 6, 8 and 10, postoperatively). The histograms showed the numbers of red blood cell (RBC), hemoglobin
(HGB), platelet (PLT), and mean platelet volume (MPV) normalized with the values
measured from non-treated rat. Each bar indicated min to max with mean as the middle
horizontal bar (n = 6, for PAH and TMV-PAH and n = 7, for RGD-PAH) ± SD. From ttest analysis comparing control (non-treatment) and experimental value, the filled bars
represented statistical significance, p < 0.05. Red dots represented outliers.
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rats was comparable with value shown in normal rat’s blood (no significant difference,
multiple t-test). There were also no significant differences in all white blood counts when
compared between each group of hydrogel implant. There were 2 outliers on day 4 white
blood counts: one, from RGD-PAH implanted group expressed increased numbers of
LYM and the corresponding WBC; another, from PAH implanted group exhibited high
NEU and its corresponding WBC. However, both rats had white blood counts leveled out
to the values comparable to all other rats after 1 post-operative week (Figure 4.2).
Other blood parameters that indicate animal health and significant loss of blood
such as red blood cell (RBC), hemoglobin (HGB), platelet count (PLT), and mean
platelet volume (MPV) were shown to be comparable to the values measured from nontreated rat’s blood in all animals that were implanted with different types of hydrogels.
Even though there were some outliers appeared at different time points for each
parameter, those outliers seemed to obtain only temporal changes in particular blood
counts that returned to the normal values at the later time point (Figure 4.3).
Organ weight can be the most sensitive indicator of an effect of drug toxicity, as
significant differences in organ weight between treated and control animals may occur in
the absence of any morphological changes.130 The spleen and liver are main target organs
for various nanomaterials in the circulatory system, because these organs are part of the
reticulo-endothelial system (RES) that has removing foreign agents from the circulation
as one of its functions. 131-133 In this study, we utilized viral nanoparticles in providing
biofunctionality to hydrogel to create extracellular matrix preferable for cell attachment
and growth. It was critical to evaluate the spleen enlargement that might occur from the
immunogenic and/or elimination reaction of the body towards viral nanoparticles
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presented in the hydrogel implants. Figure 4.4 showed that the spleen weights measured
after the animal sacrifice (at the age of 22 weeks) were not significantly different among
all groups. The corresponding mean spleen weight of all rats was 1495 ± 236 mg/kg of
total body weight, which was not statistically different from the value reported in the
literatures (p > 0.05, t-test). The mean normal spleen weight of male Sprague Dawley rat
± SD calculated from a generalized Michaelis–Menten (GMM) model, used to fit organ
weights versus age in a previous study reported by Schoeffner et al., equaled to 1029 ±
191 mg/kg of total body weight.134-136 From each animal observed at the end of the
experiment, there were no chronic and/or major inflammatory and toxicity reactions in
the RES that could cause the spleen enlargement in any group of animals.
In chapter 2, we have discussed the immunogenicity of TMV in the hydrogels
implanted subcutaneously at lower back of BALB/c mice. The assay showed nonsignificant induction of specific anti-TMV Immunoglobulin G (IgG) produced in mice.
Here, with the distinct rat cranial defect model, we re-evaluated the humoral immune
reaction causing by TMV and its RGD mutant in the hydrogels after the bone defect
replacement by TMV-PAH and RGD-PAH. From the ELISA assay, we found that TMV
and its RGD mutant within the hydrogels led to average anti-TMV titer at peak time
(week 8) below 1000. ELISA revealed higher anti-TMV antibody titers in rat sera
collected from the animals implanted with TMV-PAH than those implanted with RGDPAH hydrogels (Figure 4.5A). This observation might be due to the experimental design.
The ELISA was performed based solely on wild-type TMV (used as antigen coated on
ELISA plate). This could lead to the lower sensitivity in titer detection for the RGD-PAH
group. Since it is not clear whether the antigen binding site of antibody produced against
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Figure 4.4. Rat spleen weight at 10 week endpoint. Values expressed are means (n = 6,
for PAH and TMV-PAH and n = 7, for RGD-PAH) ± SD.
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Figure 4.5. Immune response to TMV (Anti-TMV titer) in the rats with bone substitute implant materials. Comparative serological
analysis of the immune response to each type of hydrogels was carried out by ELISA at different time points including 2, 4, 6, 8, and
10 post-operative weeks. TCID50 was shown as a titer for each plot. (A) Values expressed are means (n = 6, for TMV-PAH and n = 7,
for RGD-PAH) ± SEM. (B) Each rat responded differently in terms of the titer level and the progression of anti-TMV IgG production.
Each line connected the values analyzed from the same rat at different time points.

TMV wild-type and TMV-RGD1 share the same structure, the assay could have been
optimized using different coating for ELISA on sera collected from different groups of
animals. TMV-RGD1 mutant could have been used as the coating antigen to detect the
titer for the rats in RGD-PAH group. Another possibility could be the difference of
release profile between the wild-type TMV and the RGD mutant that escaped from the
hydrogel scaffold into the circulation. The detailed studies on in vivo bioavailability and
fate of both types of TMV releasing from the hydrogels would be carefully designed and
preceded. Figure 4.5B shows that 3 out of 6 animals implanted with TMV-PAH
expressed anti-TMV antibody as early as week 2, and the titers were continued to
increase to reach their maximum within week 8. Among 7 rats implanted with RGDPAH, 4 rats produced antibodies against TMV. However, the initial time points that the
titers were first detected varied from week 2 to week 8. Interestingly, the titers decreased
after week 8 in all rats that showed positive immune response from ELISA. This data
suggested that there were only limited amount of TMV antigen released from the
hydrogels into the circulation system. The result also emphasized in vivo safety of this
TMV-based combinatorial 3D material for tissue engineering.

4.2.3 Local inflammatory responses towards hydrogel implant
Histological sections of the explants were stained using Masson’s trichrome staining
method and evaluated the inflammation, fibrosis and connective tissue formation, and
vascularization in the hydrogels. No significant differences were detected between each
gel condition. Figure 4.6 showed that RGD-PAH had significantly higher scores on
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Figure 4.6. Histopathological analysis of bone substitute hydrogel implants. Histological scoring of three types of hydrogels in tissue
excises showed different degree of inflammation, fibrosis, and vascularization after 10 week of implantation. Values expressed are
means (n = 6, for PAH and n = 5, for TMV-PAH and RGD-PAH) ± SEM. * p < 0.05.
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inflammation and fibrosis comparing to the control PAH (t-test, p < 0.05), yet obtained
slightly higher scores than TMV-PAH with no statistical significance. Similarly, the
average scores evaluated based on both histopathological parameters for TMV-PAH were
slightly higher, but not significant, than those for PAH control. The same score trend
among three types of hydrogels was observed with the vasculature analysis, but the
differences were not statistically significant (t-test, p > 0.05), as well. The descriptive
statistics of each histopathological variable was demonstrated in Table 4.1. There were
inflammatory cells observed in the following hydrogel implants with average scores of
1.2 (PAH), 1.8 (TMV-PAH), and maximum 2.0 (RGD-PAH). The average scores of 2.0,
2.6, and 3.0 for PAH, TMV-PAH, and RGD-PAH, respectively, were given to the extent
of connective and fibrous tissue (min - max = 0 - 3) formed in the hydrogels.
Interestingly, every sample from RGD-PAH group scored maximum for inflammation
and fibrosis variables, and gained a minimum of 2 scored for vasculature. The average
scores for new blood vessels formed in each type of hydrogel (min - max = 0 - 3) are 1.7
for PAH, 2.4 for TMV-PAH, and 2.8 for RGD-PAH. Based on histological analysis of
bone excises at the defect area, the animals that were treated with hydrogels incorporated
with TMV and its RGD mutant tended to induce more physiological reactions towards
implant materials including inflammatory cells infiltration, fibrosis, and
neovascularization. One possible explanation could be that TMV might be able to induce
more cytokine production from the migrating cells at the implantation site that could lead
to more inflammatory cells recruited. The previous report by Sitasuwan et al. suggested
that some cytokine-induced neutrophil chemoattractant-1 (CINC-1), CINC-2,
macrophage inflammatory protein-3α (MIP-3α), and vascular endothelial growth factor
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Table 4.1. Descriptive statistics of variables according to the type of hydrogel implant.

95% CI of mean
Variable

Hydrogel Implant

n

Average

SEM

Lower

Upper

Min

Max

Inflammatory

PAH

6

1.2

0.3

0.4

2.0

0

2

TMV-PAH

5

1.8

0.2

1.2

2.4

1

2

RGD-PAH

5

2.0

0

2.0

2.0

2

2

PAH

6

2.0

0.5

0.7

3.3

0

3

TMV-PAH

5

2.6

0.4

1.5

3.7

1

3

RGD-PAH

5

3.0

0

3.0

3.0

3

3

PAH

6

1.7

0.4

0.6

2.8

0

3

TMV-PAH

5

2.4

0.4

1.3

3.5

1

3

RGD-PAH

5

2.8

0.2

2.2

3.4

2

3

Fibrous/Connective Tissue
91
Vasculature

(VEGF) were detected from the conditioned media for the bone marrow stromal cells
grown on TMV coated substrate.36 CINC-1 and MIP-3α recruit neutrophils and
monocytes that result in the induction osteogenesis.137 Cytokines and growth factors
secreted by infiltrated inflammatory cells including neutrophils, monocyte-derived
macrophages, and lymphocytes are the molecular messengers that promote inflammatory
events, such as neutrophil and macrophage recruitment, as well as wound healing events,
such as connective tissue synthesis and vasculature. 27, 83, 138, 139 Moreover, the RGD
peptide introduced by the incorporation of TMV-RGD1 into the hydrogel implant could
induce even more material-host interaction. Even though, it has not been conclusive
whether RGD can regulate in vivo cell adhesion to biomaterials as it does in vitro.140 Our
observation was consistent with many reports in RGD-functionalized materials
promoting materials and surrounding cells interaction in vivo. For example, Shu et al.
reported that the inclusion of covalently attached RGD peptides onto hyaluronan-based
hydrogels could enhance the formation of fibrous tissue in vivo, with increased
production of procollagen by the fibroblasts in the newly formed fibrous tissue at 4 weeks
after animal treatment.141 However, the future study with larger animal numbers should
be performed in order to confirm these results and obtain more statistically significant
analyses.

4.2.4 Bone healing analysis
The new bone formation after the hydrogel implantation was evaluated by two methods;
1) micro computed tomography (microCT) and 2) histological analysis of tissue excises
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using Masson’s trichrome staining technique. Microcomputed tomography (MicroCT) is
an X-ray–based imaging method that offers access to the 3D microarchitecture of bone. A
computer combines a stack of virtual cross-sections, interpolating sections along different
planes, to inspect the internal structure of the object. A quantitative 3D
histomorphometric evaluation (i.e., determination of the volume of bone mass and of the
microarchitecture indices of the newly formed bone) can then be performed on a cubic
volume or on an irregularly shaped volume of interest.142, 143 Here, we scanned the
regenerated bone tissue excises and quantified the new bone formed in each type of
hydrogel implants using the microCT scanner. First, measurement of the angle for
rotation and reconstruction of the 2D images were performed to ensure that all parts of
the samples were scanned properly. All 2D constructs were shown in Appendix D. Figure
4.7 showed that RGD-PAH samples gave the most average bone volume following with
TMV-RGD. PAH samples had the least mean bone volume quantified by microCT.
Nevertheless, with statistical t-test analysis, the regenerated bone volume differences
among three types of hydrogels lacked of significance. Therefore, more replicate samples
may be investigated to make this conclusion definitive.
The same samples were then subjected to histopathological analysis. Masson’s
trichrome is to show the bone and non-mineralized osteoid seen in blue (aniline blue) and
red (biebrich-scarlet), respectively. Figure 4.8 illustrated the representative image from
each type of hydrogel sample corresponding to the bone density rank that obtained
highest frequency (rat number) within each hydrogel type. The insets of Figure 4.8
depicted descriptive statistical analysis showing the frequency of each level of bone
tissue formed. For example, the histological image of RGD-PAH shown in the right panel
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Figure 4.7. Bone regeneration in critical size defect areas with porous hydrogel bone
substitutes. The bone volume regenerated in each type of hydrogel was quantified using
micro computed tomography (microCT). Values expressed are means (n = 6, for PAH
and n = 5, for TMV-PAH and RGD-PAH) ± SEM.2

2

microCT scanned and analyzed by Amy Cheng, Garcia Lab at Georgia Institute of Technology.
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Figure 4.8. Histological analysis of regenerated bone at defect sites filled with hydrogel implants. Histological sections cut coronally
through the defect after 10 weeks of implantation. The sections are stained with Masson’s trichrome and imaged at × 40 magnification.
The regenerated bone was characterized by the presence of a collagen-rich matrix stained blue. The inset pie charts represented the rat
numbers that developed different degree of bone regeneration at the defect site.

of Figure 4.8 corresponded to the sample that was stained dense bone tissue (weighted
60% of total rats treated with RGD-PAH). Figure 4.8 showed that the rats that received
RGD-PAH implants had more probability to regenerate higher density of bone.
Following by the group that was treated with TMV-PAH, 60% of the animals in this
group could regenerate few or medium bone tissue. The group with PAH alone had the
most probability in having none or rarely seen bone formation. This analysis suggested
that by incorporating TMV particle into the hydrogel scaffold, the bone regeneration
could be enhanced. Moreover, TMV-RGD1 mutant further improved the new bone
formation bridging the cranial bone defects. This result also corresponded to the
histological analysis from previous section. Among combinations of hydrogel types,
Pearson’s statistical correlation test showed correlations between bone tissue formation in
the hydrogel implants and two isolated histopathological variables including
fibrous/connective tissue (correlation coefficient; r = 0.6) and neovascularization (r =
0.6). This study suggested, in consistence with many other studies, that RGD, when
attached to the implanted scaffolding materials, played an important role in cell
recruitment that could eventually help promote bone regeneration.144-146

4.3 CONCLUSION
The viral particle functionalized PAHs were comparatively investigated in terms of
inflammation and healing of confined critical size cranial bone defects in rats. In vivo,
TMV- and RGD- PAH permitted the healing of critical size defects in the cranial
segmental bone of rats, as did the PAH control gel, but, unlike the latter, RGD-PAH
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improved bone remodeling and maturation. The hydrogels elicited neither a systemic
inflammatory reaction, nor a severe immunogenic adverse effect. Therefore, virus-based
combinatorial porous alginate hydrogel is potentially useful as bone replacement material
in reconstructive orthopaedic surgery, being a readily available biomaterial able to
improve bone healing and maturation. However, more animal research with other model
of bone defects (e.g., tibia and femur) and other higher animal may be needed before
translation to clinic.

4.4 EXPERIMENTAL SECTION
All chemicals were obtained from commercial suppliers and used as received unless
otherwise noted. Wild-type TMV (TMV) and its RGD mutant (TMV-RGD) were isolated
from infected tobacco leaves following previously established protocols.23

4.4.1 Synthesis of Virus-Incorporated Porous Alginate Hydrogels.
The incorporation of TMV and its mutant (TMV-RGD) in porous alginate hydrogel was
based on previously reported methods.37 Briefly, 5% w/v low viscosity sodium alginate
(Protanal LF 10/60 FT, 30 − 60 mPas for 1%, kindly provided by FMC Biopolymer UK
Ltd.) was dissolved in 2% w/v sodium bicarbonate (NaHCO3) and 4% w/v pluronic F108
solution. Molar equivalent of citric acid with respect to NaHCO3 was added to the
mixture while stirring at 500 rpm using overhead stirrer, 115V. Stirring was continued for
15 min at room temperature to allow CO2 to fully develop. For the PAH modified with
TMV (TMV-PAH), or PAH modified with mutant TMV-RGD (RGD-PAH), 0.1% w/v of
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virus was added to the solution 10 min after adding citric acid. The mixture was stirred
for another 5 min. Afterward, the foamy alginate solution was cast in 6.35 mm (0.25
inches) diameter, 2 mm thick aluminum mold and freeze-dried. The resulting solid foam
disc was soaked in 2 M of CaCl2 for 24 h to induce the formation of the calcium-based
physical gel and then dialyzed against large volume of 0.1 M CaCl2. Finally, the solid
foam was freeze-dried, resulting in porous alginate hydrogel (PAH) for implantation in
animal study.

4.4.2 Animals, Lethality Test and Animal Treatments.
The procedures were performed in accordance with the guidelines for animal
experimentation and the protocol approved by the Institutional Animal Care and Use
Committee, University of South Carolina. NIH guidelines (or for non-U.S. residents
similar national regulations) for the care and use of laboratory animals (NIH Publication
#85 - 23 Rev. 1985) have been observed. Twelve-week-old male Sprague-Dawley rats
were housed at 22 ± 2 °C with a 12/12 h light/ dark cycle and fed standard rodent chow
and water ad libitum. Twenty-one rats were randomly assigned to experimental groups.
Two groups that were implanted by TMV-PAH, and RGD-PAH consisted of 7 rats each.
Another group implanted by PAH consisted of 6 rats. Disk-shaped hydrogels were
implanted to fill the cranial bone defects created in the surgery. Rats were given 2 - 4
mg/kg of Carprofen 2 - 4 hours before surgery subcutaneously for analgesia. Procaine
penicillin (60,000IU) was given SQ for infection prophylaxis. Instruments were
autoclaved prior to use to minimize risk of post-surgical infection and cross
contamination. The animal was anesthetized with 3% isoflurance in oxygen. After the
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appropriate plane of anesthesia was obtained, the fur over each animal's cranium was
shaved and the skin was cleansed with normal saline to remove loose hair. A dry heating
pad was used to keep the animal warm during surgery. A midline incision was made from
the middle of the nasofrontal area to the external occipital protuberance, utilizing a sterile
No. 15 scalpel blade. Full-thickness skin flaps will be reflected laterally with a periosteal
elevator to expose the calvaria. An 8-mm craniotomy was performed in all animals
utilizing a dental handpiece system at low speed and with copious sterile saline irrigation
to remove loose debris and to avoid generation of frictional heat at the surgical site. Bone
defects were standardized by using an 8-mm diameter trephine bur to outline the
treatment area. A PTFE barrier membrane (Osteogenics Biomedical, Lubbock, TX) was
inserted to form a barrier on top of the dura. Next, the hydrogel scaffold was carefully
placed into the defect and the second PTFE membrane was placed over the defect and
under the periosteum. The periosteum was repositioned and closed utilizing continuous
interlocking sutures using Nylon suture material. Postoperative analgesia to relieve pain
with carprofen (2 - 4 mg/kg) was given orally at least once every 24 hours for 48 hours.
The animals were weighed immediately before/after surgery and daily afterward for the
first 2 days. Then they were weighed once a week until the experiment ended. Signs of
pain or distress were monitored daily after surgery.
Blood withdrawal was performed on day 4, weekly at the first 4 weeks, and
biweekly until the end point at week 10, after the surgery. Blood samples from all
animals were subjected to total blood count and antigen-antibody ELISA assay specific to
TMV. Three-hundred microliters of blood was withdrawn from the tail vein while the
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animals were restrained using a restraint tube. After iodine scrub, a butterfly needle was
inserted into the vein. The blood was then collected into the collection tube.
At 10 week time point, the animals were euthanized. The implants were recovered
together with their surrounding tissues. The excised implants with the surrounding tissues
were then preserved in 10% neutral-buffered formalin for subsequent analyses. The
spleen of every rat was isolated and weighted.

4.4.3 Micro computed tomography
The samples and the surrounding bone tissues were fixed in a 10% formalin solution for
micro-computed tomography (Micro-CT, Skyscan 1076, Skyscan, Belgium) analysis and
histopathology study 1 and 2 months after implantation. MicroCT was used to observe
the new bone formation in the defected skull site. Each sample was fixed on the object
stage, and imaging was performed on the sample for 360° of rotation with an exposure
time of 20 min. MicroCT images were reconstructed over the region of interest (ROI)
using CTAn (Skyscan) and CTVol (Skyscan) to make 3D images.

4.4.4 Hematological assay.
Complete Blood Count (CBC) was preceded right after each blood withdrawal. The
blood sample of 10-50 µL was transferred into 1 mL BD Microtainer Tube with
Dipotassium EDTA. Each tube was subjected to the automated blood counter machine,
model VetScan HM5 Hematology System. The numbers of total white blood cell (WBC),
neutrophil (NEU), monocyte (MON), lymphocyte (LYM), red blood cell (RBC),
hemoglobin (HGB), platelet (PLT), and mean platelet volume (MPV) were recorded and
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analyzed according to the calibrated instrumental protocol, which indicated the normal
range of each parameter.

4.4.5 Paraffin Embedding and Histological Assays.
The formalin preserved implanted hydrogels/tissues of all rats were decalcified using 10%
formic acid in formalin for 1 week and then embedded in paraffin blocks individually
with proper orientations. Tissue sections (5 µm) were prepared and stained with
Masson’s trichrome. Based on the amount of inflammatory cells (basically lymphocytes,
neutrophils, macrophages, and so on) observed within areas of implants, the degree of
tissue inflammation was scored as 0, 1, and 2 (normal: none or rarely seen, slightly
increased: 5 to 20 per × 40 objective field, and obviously increased: > 20 per × 40
objective field). Based on the degree of fibrous/connective tissues and capillary blood
vessels observed within the areas of implants, the tissue fibrosis and vasculization were
scored as 0, 1, 2 and 3 (none, rarely seen; ≤ 2 vessels/

40 field, slightly increased; 3 -

10/ × 40, and obviously increased; > 10 vessels/ × 40 field, respectively). Bone
regeneration was evaluated on the same tissue sections and given the degree of new bone
formation as follows: none or rarely seen; ≤ 2 per

40 field, few or moderate; 3 - 10 per

× 40 field, and dense; > 10 per × 40 field. Histological images were taken by using a
Nikon microscope and an Olympus digital camera.

4.4.6 Enzyme-Linked Immunosorbent Assay (ELISA).
The serum samples for ELISA were obtained after centrifugation (2,000 g, 15 min, 4 °C)
of blood samples collected from every animal and stored at -80 °C. ELISA was
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performed no later than 3 months after the sera were collected. To coat wells with TMV
antigen, high protein-binding conical bottom 96-well plate was used. Wild-type TMV (10
µg/mL, 100 mL) in phosphate buffer saline (PBS) was added to the microwells and
incubated for 1 h at room temperature, followed by three PBS washes. Blocking for nonspecific binding was performed by adding 100 µL of 1% bovine serum albumin (BSA)
and incubating for 30 min at room temperature, followed by three PBS washes. Binding
was performed by adding 100 µL of serially diluted antiserum into microwells and
incubating for 1 h at room temperature, followed by thorough washes. HRP conjugate
anti-mouse IgG (Cayman Chemical Company) diluted at 1:20000 ratio was added and
incubated for 30 min at room temperature. Tetramethyl benzidine (TMB Plus, Amresco)
and 1 M H2SO4 were added in sequence to the wells according to the manufacturer’s
protocol, and the binding efficiency was monitored by measuring absorbance at 450 nm.
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CHAPTER 5
CHONDROGENIC DIFFERENTIATION OF BONE MARROW STROMAL CELLS IN THREEDIMENSIONAL CULTURES
5.1 INTRODUCTION
5.1.1 Hydrogels as scaffolds for chondrogenesis of bone marrow stromal cells
Cartilage tissue engineering has been of significant interest with incessant efforts in
research and development because damaged human articular cartilage lacks the ability for
self-repair.147-149 Current clinical methods to repair defective cartilage are limited in their
ability to regenerate functional cartilage both in terms of composition and mechanics.149
In replicating the native cartilage microenvironment, hydrogels provide cell support and
display high water retention.150 Many studies have evidenced that hydrogel-based
biomaterials can offer an instructive three-dimensional (3D) microenvironment for
chondrogenesis of stem cells in vitro, and can serve a delivery system for cell-based
therapies in vivo.150-152
Bone marrow stromal cells (BMSCs) have emerged as a clinically relevant cell
source for regenerative medicine due to their potential to differentiate into several
mesenchymal lineages including cartilage, bone, and fat.153, 154 The multipotent
differentiation of BMSCs is regulated by both soluble and physical factors present in the
extracellular microenvironment, including cell-cell and cell-matrix interactions, features
that can be engineered into a range of natural and synthetic biomaterial scaffolds.155
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The scaffolds not only provide structural support for chondrogenesis of BMSCs, but also
control the differentiation through the design that imitates components of the natural
extracellular microenvironment.156, 157

5.1.2 Tobacco mosaic virus as bionanoparticle to functionalize hydrogels
Here, we utilized the tobacco mosaic virus (TMV) as a functional nano-scaffolding
material to decorate the hydrogel with multivalent RGD peptide, i.e. a common integrinbinding motif, through its RGD mutant. RGD has been shown to influence both
chondrogenesis and osteogenesis in alginate hydrogels in dose-dependent manner.156, 158,
159

The degree of cellular adhesion to the environment (e.g., through changes in ligand

density) regulates integrin clustering, cytoskeletal organization, overall morphology, and,
specifically in the case of stem cells, differentiation.160-163 In Chapter 1, we explored the
use of this virus functionalized hydrogels by studying the cell adhesion and osteogenic
differentiation of BMSCs in 3D environment. The porous alginate hydrogel (PAH)
scaffold was modified with TMV (TMV-PAH) and TMV-RGD1 mutant (RGD-PAH).
The virus-functionalized hydrogels were cyto-compatible in vitro (Chapter 1), and
biocompatible in mice and rats (Chapter 2 - 4). The RGD motif presented in the hydrogel
was shown accessible to the cells by the increase in cell binding. Moreover, the hydrogels
allowed the osteogenic differentiation with higher degree of mineralization in virusfunctionalized hydrogels. In this chapter, we laid the concept of easy-to-functionalize
hydrogel scaffold with controllable RGD dose and multivalency via viral nanoparticle on
chondrogenesis of BMSC in 3D culture and characterization.
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5.2 RESULTS AND DISCUSSION
5.2.1 Chondrogenesis primer optimization
In this chapter, gene expression for 4 chondrogenesis marker proteins including
Aggrecan, COMP (Cartilage Oligomeric Matrix Protein), Collagen II, and Sox9 were
proposed to be used for characterization of the cartilage differentiation of BMSCs in 3D
porous hydrogel scaffolds. First, Aggrecan is a cartilage-specific proteoglycan core
protein (CSPCP) or chondroitin sulfate proteoglycan 1 that performs as an integral part of
the extracellular matrix (ECM) in cartilaginous tissue. This molecule is important in the
proper functioning of articular cartilage because it provides a hydrated gel structure (via
its interaction with hyaluronan and link protein) that endows the cartilage with loadbearing properties. It is expressed by chondrocytes and is also crucial in chondroskeletal
morphogenesis during development.164 Second, cartilage oligomeric matrix protein
(COMP) is a non-collagenous ECM protein expressed primarily in cartilage, ligament,
and tendon. The molecular functions of COMP include: binding other ECM proteins,
catalyzing polymerization of type II collagen fibrils, and regulation of chondrocyte
proliferation.165 Third, the synthesis of type II collagen is initiated as mesenchymal cells
differentiate into chondrocytes. The level of cytoplasmic type II collagen mRNA
progressively increases during the course of chondrogenesis, which parallels the
progressive accumulation of cartilage matrix by cells.166 These three protein markers
mentioned are considered as the essential parts of the cartilage ECM. Another important
chondrogenic protein marker, Sox9 is a transcription factor with a high-mobility group
(HMG-box) DNA-binding domain exhibiting a high degree of homology with that of the
mammalian testis-determining factor, SRY. During chondrogenesis, Sox9 is expressed in
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all chondroprogenitors and all differentiated chondrocytes. This transcription factor is
required in several successive steps of the chondrocyte differentiation pathway during
endochondral bone formation in vivo and for the proper progression of cells through the
sequential steps of this process. Akiyama et al. emphasized that Sox9 is needed for the
commitment of undifferentiated mesenchymal cells to a chondroprogenitor.167 To study
these genes, we first verified the primers and optimized the reverse transcription
polymerase chain reaction (RT-PCR) condition using the commercial cartilage cDNA.
The primer sequences for these genes were listed in Table 5.1. Figure 5.1
represented the corresponding RT-PCR products on agarose gel suggesting the validity of
the primers and the respective RT-PCR condition for Sox9 (lane B), COMP (lane C),
Aggrecan (lane D), and GAPDH (lane E). However, the RT-PCR product of Collagen II
could not be synthesized from the same batch of cDNA (lane A), even with the increased
dose of primers (up to 0.4 µM) and/or greater cDNA concentration.

5.2.2 Chondrogenesis gene expression
The genes related to chondrogenesis were studied from the differentiated BMSCs in
PAH, TMV-PAH, and RGD-PAH cultured with chondrogenic media. Figure 5.2 showed
the quantitative PCR results from day 18 culture normalized with non-induced BMSCs
day 0. Overall, there were insignificant upregulations of all chondrogenic marker genes
for Aggrecan, COMP, and Sox9 with no statistical significance among different types of
hydrogels. The standard deviation (SD) expression of each gene normalized with
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Table 5.1. Primers used for RT-PCR and RT-qPCR to measure chondrogenesis gene
expression.

Gene

Sequence (5'-3')

Reference

GAPDH

Forward: ACTAAAGGGCATCCTGGGCTACACTGA

17

Reverse: TGGGTGGTCCAGGGTTTCTTACTCCTT
Aggrecan

Forward: GGCCTTCCCTCTGGATTTAG

168

Reverse: CCGCACTACTGTCCAAC
C MP

Forward: TGACTTCGATGCTGACAAGG

168

Reverse: GAACGATCTCCATTCCCTGA
Sox9

Forward: CTGAAGGGCTACGACTGGAC

168

Reverse: TACTGGTCTGCCAGCTTCCT
Collagen II

Forward: AGGGGTACCAGGTTCTCCATC
Reverse: CTGCTCATCGCCG CGGTCCGA
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Figure 5.1. Agarose gel image of RT-PCR products derived from cartilage cDNA used
for primer and PCR optimization. Gel image showed the PCR products of house-keeping
gene (lane E), Aggrecan (lane D), COMP (lane C), and Sox9 (lane B). There was no
product appeared for Collagen II gene (lane A).
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Figure 5.2. Gene expression levels of chondrogenesis markers after chondrogenic
induction of BMSCs cultured in PAH, TMV-PAH, and RGD-PAH for 18 days.
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housekeeping gene (GAPDH) and among triplicate samples were very high due to the
poor quality and quantity of messenger RNA extracted from the hydrogels. Aiming for a
quality RNA extraction from polysaccharide based scaffolds is extremely challenging.170172

However, the improvement in RNA purification method is required for more

conclusive data.

5.2.3 Collagen II immunohistochemical staining
Immnofluorescence imaging in Figure 5.3 showed that the chondrogenic-induced BMSCs
cultured in TMV-PAH and RGD-PAH stained positive for type II collagen after 18 days
with higher fluorescence intensity than it appeared in PAH. It is likely that TMV and
RGD-TMV could enhance the differentiation of BMSCs into chondrocyte. With very
limited data, thus far, a possible justification at this point could be that TMV particles
might induce the chondrogenesis through the stimulation of bone morphogenic protein-2
(BMP-2) as it has been suggested by Sitasuwan et al. in osteogenesis of BMSCs.17
Likewise, the BMPs have been identified by virtue of their ability to promote cartilage
formation, especially in commitment and condensation during chondrogenesis.173-175
Therefore, more detailed study in expression of BMPs is necessary to rule out this
hypothesis.
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Figure 5.3. Immunofluorescence images of chondrogenic differentiated BMSCs in 3D
virus functionalized hydrogels stained for nucleus (blue) and Collagen II (red).
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5.3 CONCLUSION
In this chapter, we have verified the primers and the PCR condition used for
chondrogenic gene study including Aggrecan, COMP, and Sox9. When BMSCs were
culture with chondrogenic supplemented media in 3D hydrogels with virus nanoparticles
(TMV-PAH and RGD-PAH), collagen II was accumulated and that could eventually lead
to the cartilage-like tissue formation with the ECM components secreted during the
differentiation and the 3D supports provided by the hydrogel scaffolds. However, the
appropriate solid data should be continued to explore in order to make the argument
conclusive. In conclusion, this virus functionalized porous alginate hydrogel system is
considered a prototypical concept for the development of biomaterials to study the
regulation of multivalent-displayed biofunctionality or specific scaffold chemistry
towards cartilage differentiation of stem cells in 3D.

5.4 EXPERIMENTAL SECTION
All chemicals were obtained from commercial suppliers and used as received unless
otherwise noted. Wild-type TMV (TMV) and its RGD-mutant (TMV-RGD1) were
isolated from infected tobacco leaves following previously established protocols.23

5.4.1 Synthesis of virus-incorporated porous alginate hydrogels
The synthesis of gas template solid foam was based on the methodology reported by
Barbetta et al.28 Briefly, 5% w/v low viscosity sodium-alginate (Protanal® LF 10/60 FT,
30 - 60 mPas for 1%, kindly provided by FMC Biopolymer UK Ltd.) was dissolved in
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2% w/v sodium bicarbonate (NaHCO3) and 4% w/v pluronic F108 solution. Molar
equivalent of citric acid with respect to NaHCO3 was added to the mixture while stirring.
Stirring was continued for 15 min to allow CO2 to fully develop. Afterward, the foamy
alginate solution was flash frozen in liquid nitrogen and freeze-dried. The resulting solid
foam was soaked in 2 M of CaCl2 for 24 h to induce the formation of the calcium-based
physical gel and then dialyzed against large volume of 0.1 M CaCl2. Finally, the solid
foam was freeze-dried, resulting in porous alginate hydrogel (PAH). For the TMV
modified PAH (TMV-PAH), or mutant TMV-RGD1 modified PAH (RGD-PAH), 0.1%
w/v of virus was added to the solution 10 min after adding citric acid. The mixture was
stirred for another 5 min.

5.4.2 Bone Marrow Stem Cells (BMSCs) isolation and culture
Primary BMSCs were isolated from the bone marrow of young adult 160-180 g male
Sprague Dawley rats (Charles River Laboratories). The procedures were performed in
accordance with the guidelines for animal experimentation by the Institutional Animal
Care and Use Committee, School of Medicine, University of South Carolina. Cells were
maintained in complete primary media (Dulbecco’s Modified Eagle’s Medium (DMEM)
supplemented with 10% fetal bovine serum (FBS)), kept at 37°C in a CO2 incubator with
5% CO2 : 95% air and passaged no more than seven times after isolation.

113

5.4.3 Cell seeding and chondrogenic culture
Lyophilized PAH, TMV-PAH, and RGD-PAH scaffolds were cut to 3 × 3 × 2 mm3
cubes. For quantitative real-time RT-PCR, each set of experiment (N) contained six
hydrogels per type of scaffold. For immunostaining experiment, one hydrogel per sample
was used. Hydrogels were sterilized in 70% ethanol for 15 min, ethanol was drained on
sterile filter paper and the hydrogels were further sterilized under UV-light for 60 min in
laminar airflow hood. Hydrogels were then saturated in chondrogenic supplemented
media at 37°C for 60 min, blotted excess media with sterile filter paper, and placed in 12well non-adhesive plate. BMSCs were harvested from 80% confluent culture flask using
0.25% trypsin/EDTA (Cellgro) for 5 min and counted and re-suspended in complete
primary media. 4 × 103 BMSCs were seeded per one volume (mm3) of hydrogel. Rat
BMSCs loaded hydrogels were initially incubated with 200 μL of chondrogenic media in
each well to prevent hydrogels from drying out. After 6 h of an initial incubation,
hydrogels were completely submersed in 1 mL of chondrogenic media in each well. The
hydrogels seeded with BMSCs were cultured at 37°C and 5% CO2.
Chondrogenic supplemented media comprised of DMEM (Hyclone, Thermo
scientific), 1% fetal bovine serum (Atlanta biologicals), 1 × Penicillin-StreptomycinAmphotericin B (from MP Biomedicals,100 U/mL penicillin and 1000 U/mL
streptomycin solution, 0.25 μg/mL amphotericin B antimycotic), 100 nM dexamethasone
(Enzo Life Sciences), 10 ng/mL TGF β1 (R&D System), 50 μg/mL ascorbic acid (SigmaAldrich), 1 mM sodium pyruvate (Hyclone, Thermo scientific), 1 × ITS+3(from SigmaAldrich, contains 1.0 mg/ml insulin from bovine pancreas, 0.55 mg/mL human transferrin
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(substantially iron-free), 0.5 μg/mL sodium selenite, 470 μg/mL linoleic acid, 470 μg/mL
oleic acid and 50 mg/mL bovine serum albumin), 2 mM l-glutamine (Hyclone, Thermo
scientific) and 40 μg/mL l-proline (Sigma-Aldrich).176, 177 Medium was replaced thrice in
a week and cultures were harvested at day 18.

5.4.4 RT-PCR
Rat cartilage cDNA (Zyagen) was used to verify the primers for cartilage related genes
including Aggrecan, COMP, Sox9, and Collagen II and to optimize the quantitative realtime RT-PCR condition. RT-PCR was then achieved by the method described as: 45
cycles of PCR ( 95°C for 20s, 60°C for 15 s, and 72°C for 15 s), after initial denaturation
step of 5 minutes at 95°C, by using 0.1 μL of Taq DNA polymerase, 0.5 μL of 10 mM
dNTP Mix, 2.5 μL of 10X PCR Buffer, without Mg, 2 pmol/μL of each forward and
reverse primers and 30 ng cDNA templates in a final reaction volume of 25 μL. The
primer sequence used was listed in Table 5.1. The PCR product was then subjected to
standard agarose DNA gel electrophoresis.

5.4.5 Quantitative real-time RT-PCR analysis (RT-qPCR)
The chondrogenic cell cultures were terminated after 18 days. At the termination time
point, the hydrogels were flash frozen then immediately disrupted by high speed
homogenization in the prechilled RNAzol® RT reagent (MRC). The tissue homogenizer
probe was rinsed with RNase-free water and 10% sodium lauryl sulfate between each
sample processing to prevent cross-contamination. Total RNA was subsequently
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extracted following manufacturers’ protocols of RNAzol® RT (MRC). The resulting
RNA was reverse transcribed by using qScript™ cDNA Supermix (Quanta Biosciences).
The number of samples for each experiment (n) was six and each experiment was
repeated (N) three times. The quality and quantity of the extracted RNA was analyzed
using Bio-Rad Experion (Bio-Rad Laboratories) and was reverse transcribed by using
qScript™ cDNA Supermix (Quanta Biosciences). RT-qPCR (iQ5 real-time PCR
detection system Bio-Rad Laboratories) was done by the method described as: 45 cycles
of PCR (95°C for 20s, 60°C for 15 s, and 72°C for 15s), after initial denaturation step of
5 minutes at 95°C, by using 12.5 μL of iQ5 SYBR Green I Supermix, 2 pmol/μL of each
forward and reverse primers and 2 - 5 μL cDNA templates in a final reaction volume of
25 μL. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as the
housekeeping gene. Data collection was enabled at 72°C in each cycle and CT (threshold
cycle) values were calculated using the iQ5 optical system software version 2.1.
Quantification of gene expression was based on the CT value for each sample which was
calculated as the average of three replicate measurements for each sample analyzed using
the same software. The primers used for RT-qPCR are shown in Table 5.1. The primers
were synthesized commercially (Integrated DNA Technologies, Inc.), and evaluated for
an annealing temperature of 60°C.

5.4.6 Immunohistochemistry staining for type II collagen
Immunostaining was performed to observe the presence of collagen II. rBMSCs culture
in PAH, TMV-PAH, and RGD-PAH were terminated after culturing 18 days in
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chondrogenic media. Hydrogels were washed three times with 100 mM cacodylated
buffer and then fixed in 2.5% glutaraldehyde in cacodylated buffer overnight. The fixed
samples were then permeablized for 15 min in TBST (0.05% Tween20) and blocked in
2% w/v bovine serum albumin (BSA, Sigma–Aldrich) in TBS for 20 min with gentle
agitation at room temperature. After blocking, the hydrogels were incubated for 2 h with
primary antibody targeting the type II collagen (Sigma-Aldrich) at 1:100 dilution.
Secondary antibody detection Alexa Fluor® 546 (Molecular Probes, Invitrogen) was used
at 1:200 dilutions in blocking buffer for 1 h at room temperature. In the end, the
hydrogels were washed with TBS and counter-stained with DAPI (nuclear staining).
Images of the stained samples were obtained using Olympus IX81 with epi-flour mode
under 20x objective lens (for PAH and TMV-PAH) and 10x objective lens (for RGDPAH). Exposure times were kept constant for all samples (50 ms for DAPI and 1000 ms
for collagen II).
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CHAPTER 6
IN SITU CROSSLINKING HYDROGELS WITH CYSTEIN-ADDED MUTANT OF TOBACCO
MOSAIC VIRUS FOR STEM CELL ENCAPSULATION AND CULTURE
6.1 INTRODUCTION
6.1.1 Viral nanoparticle as a versatile nano-sized biomaterial in biomedicine
Plant viruses or virus like particles (VLPs) are becoming attractive platforms in variety of
biomedical applications. Due to the simplicity of their genome, viruses use repetitive
protein units to construct their capsids, which lead to highly organized structures on the
surface.178 This can provide a highly ordered platform to display various functionalities in
high density. By designing the plant virus with simple functional groups, previous reports
have shown that the tobacco mosaic virus (TMV), as nanometer sized building block, can
support mammalian cells and dramatically improve the transformation of bone marrow
derived mesenchymal stem cells (BMSCs) into bone-like cells in the laboratory. 36, 37
Moreover, Sitasuwan et al. reported the acceleration of bone differentiation with
overexpressed BMP-2 gene in osteogenic induced BMSCs when grown on wild-type
TMV based substrate.17 Our aim was to implement these tissue responses in 3D hydrogel
system in an injectable format for cartilage tissue engineering. The design of this study
based on the covalent crosslinking of TMV particles onto the polymer backbone of
injectable hydrogel. The polymer backbone functionalized with (meth)acrylate groups
that can undergo Michael addition reaction with thiol molecules. Native TMV particles
are nearly unreactive towards thiol-selective reagents including meth(acrylate).38
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Therefore, in this chapter, we utilized a cysteine added mutant of TMV (TMV-1Cys) to
serve the crosslinking purpose. Cys mutant of TMV has been successfully expressed in
tobacco plants and purified in large quantities to utilize the virus platform in various
application including vaccine carrier76, DNA microarrays179, 180, and battery electodes.181

6.1.2 Hyaluronic acid as a hydrogel-forming biopolymer
Hyaluronic acid (HA) is a mucopolysaccharide that binds to water giving it a stiff viscous
quality similar to “Jello”. It is natively found in most connective tissues and is
particularly concentrated in human synovial fluid, the vitreous fluid of the eye, umbilical
cords, nasal cartilage and rooster combs.182 It is naturally synthesized by a class of
integral membrane proteins called hyaluronan synthases, and degraded by a family of
enzymes called hyaluronidases that are found throughout the body or through oxidative
mechanisms to yield oligosaccharides and glucuronic acid.183, 184 The biological functions
of HA include maintenance of the elastoviscosity of liquid connective tissues such as
joint synovial and eye vitreous fluid, control of tissue hydration and water transport,
supramolecular assembly of proteoglycans in the extracellular matrix (ECM), and
numerous receptor-mediated roles in cell detachment, mitosis, migration, tumor
development and metastasis, and inflammation.185-189 HA is a linear chain polymer of
repeating units of disaccharide, β-1,4-D-glucuronic acid–β-1,3-N-acetyl-Dglucosamine.182, 190 The polymer possesses properties desirable for tunable scaffolds for
tissue engineering as a wide range of molecular weights can be obtained, as well as the
presence of chemically modifiable groups (hydroxyl and carboxyl groups) on the
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backbone. Functionalized HA with reactive groups such as methacrylates and acrylates
has been utilized to form HA-based hydrogels for controlling stem cell differentiation.191194

HA hydrogel can also be further engineered to obtain different physical and chemical

properties. For example, gelation time and mechanical property of the hydrogel could be
tailored by altering the degree of modification of HA (methacrylation of HA) and/or the
concentration of HA.195

6.1.3 Injectable hydrogel for cell encapsulation and tissue engineering
In situ gelling hydrogel system is currently of significant interest for tissue engineering
applications due to its advantages over the pre-formed hydrogel scaffold. The key
benefits include 1) cell encapsulation occurred as the gelation progress eliminating a
concern over limited cell penetration into scaffold; 2) better cell-material contact closely
resembling the natural tissue environment; 3) in situ molding feature capable of filling
irregular shape defect and providing better tissue integration; and 4) minimally invasive
route of administration improving patient compliance.84, 196-198 Injectable hydrogel
requires that the gel precursors can be gelled under mild conditions driven by physical
changes like pH value, temperature, ionic concentration, and/or chemical crosslink
reactions.17 Here, we used hyaluronic acid (HA) as the hydrogel forming polymer to
design the virus-incorporated injectable hydrogel. HA backbone was modified to have the
reactive methacrylic group and the gel could be formed the physiological condition in
situ upon addition of dithiothreitol (DTT) crosslinker via thiol-ene Michael addition
reaction.190, 195 The incorporation of TMV could be proceeded through the same thiol-ene
reaction between thiol group of TMV-1Cys mutant and the methacrylated HA polymer.
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Together with the previous observation that 2D TMV coated substrate could regulate
early stem cell differentiation, we hypothesized that TMV displayed in a 3D hydrogel
system could affect the hydrogel material properties and direct cell responses. In this
study, we characterized the physical properties of hydrogels including viscoelasticity and
gelation behaviors, the cross-linked TMV particles within the hydrogel, and the stem cell
response after encapsulation in the TMV-based hydrogel.

6.2 RESULTS AND DISCUSSION
6.2.1 HA-methacrylate synthesis and chemical characterization
Firstly, to fabricate the hydrogels, HA was functionalized with methacrylate groups using
a simple, one-step reaction with methacrylic anhydride. Methacrylate groups were then
crosslinked via a rapid Michael addition reaction with thiol-containing molecules. In our
experiment, the cysteine-containing coat protein subunits of TMV-1Cys and dithiothreitol
(DTT; a small molecule crosslinker) were used as the crosslinkers (Figure 6.1). Thiol(meth)acrylate Michael addition is an efficient reaction that may be completed in aqueous
medium at physiological temperature and pH in the presence of proteins or cells.199-202
We synthesized many variants of methacrylated HA as listed in Table 6.1. An
excess of methacrylic anhydride with respect to HA was often used because of the limited
solubility and potential hydrolysis reaction of methacrylic anhydride in aqueous medium.
By varying HA monomer : methacrylic anhydride molar ratio, we consistently obtained
low (~ 10%), medium (~ 40 - 50%), and high (100%) degree of modification of HA
backbones (~ 47 kDa MW) as determined by 1H NMR (Appendix E).
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Figure 6.1. Injectable hydrogel from virus-linked biopolymer. The hydrogel synthetic scheme illustrated the incorporation of TMV in
the in situ crosslinked hydrogel (A). Hyaluronic acid (HA) was reacted with different molar excesses of methacrylic anhydride to yield
methacrylated HA in various degrees of modification (A1). TMV-Cys mutant was linked to methcrylated HA backbone via thiol-ene
click reaction (A2).

Table 6.1. Percent degree of methacrylation of different macromer size HA when
reacting with various molar ratio of methacrylic anhydride.

MW of HA

HA monomer : Methacrylic anhydride molar ratio
1:3

1:6

1:10

1:12

47 kDa

~ 10%

~ 40-50%

100%

100%

310 kDa

N/A

~ 30%

N/A

~ 75%

1 MDa

N/A

Not detectable

N/A

N/A

N/A data not available
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Slightly lower percentage of modification could be obtained from the higher molecular
weight HA (310 kDa) using the same reaction condition with 1:6 and 1:12 HA monomer
: methacrylic anhydride molar ratio. Nonetheless, the degree of modification could not be
detected by 1H NMR when the same reaction condition applied to 1M Da HA, likely due
to the high viscosity of the HA solution which reduces the reaction rate. Thus, the
modification reaction of high molecular weight HA could be optimized by reducing the
concentration of HA polymer. By far, giving optimum viscosity and modularity in a wide
range of % methacrylation, 47 kDa HA macromere seemed feasible for our experiment.
The rational supporting the use of relatively small HA macromer (around 50 kDa)
was also based on the report by Chung et al. They suggested that the hydrogels fabricated
from 2 wt% of the 50 kDa HA macromer most resembled the properties of native
cartilage and showed the greatest promise for continued development for cartilage
regeneration when compared to the hydrogels from the larger HA (tested up to 1100
kDa).190, 203 For the purpose of future chondrogenic (cartilage) differentiation study of
BMSCs, 47 kDa HA was used for the rest of this report. For consistency of the
nomenclature for each hydrogel formulation in this report, the terms, “TMV-SH, 0.1% +
xx-DMHA, 5%” and “xx-DMHA, 5%,” represent for TMV-1Cys modified methacrylated
HA hydrogel and non-modified methacrylated HA hydrogel, respectively; with xx-DM
indicating degree of methacrylation of HA polymer.
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6.2.2 Gelling behavior and mechanical characterization of HA hydrogels
TMV-1Cys (TMV-SH) mutant contained cysteine in addition to the wild-type TMV at Nterminus of its hierarchically assembled coat proteins (see Appendix F for TEM image of
TMV-1Cys). We covalently conjugated TMV-1Cys to methacrylated HA backbone via
Michael addition reaction. The methacrylated HA functionalized with TMV-SH prehydrogel solution was then crosslinked to create hydrogel with DDT via the same thiolene reaction. Oscillatory rheology was used to study sol-to-gel transition. The DTT
molecular crosslinker was added to the pre-hydrogel solution (with and without TMVSH) right before loading sample onto the rheometer. The gelation time of each hydrogel
was determined from crossing-over between storage modulus and loss modulus. Storage
modulus G' and loss modulus G" are parameters describing the rheological properties of
viscoelastic polymeric materials. Storage modulus G' defined by the ratio of elastic stress
to strain, describes the amount of stored (saved) energy during shear, and refers to the
elastic properties of the material. Loss modulus G" expressed by the ratio of viscoelastic
stress to strain, shows how much energy was dissipated in a cycle of deformation in the
form of heat and defines the viscous properties of the material.204, 205Here, we observed
substantially faster gelation time when TMV-SH was attached and incorporated into the
hydrogel (Figure 6.2). Figure 6.2A showed that the modulus cross-over appeared much
earlier in the hydrogel formulation with 0.1 wt% TMV-SH. The same study was repeated
for 3 times, and the significant difference of average gelation times of the hydrogel with
and without TMV-SH was displayed in Figure 6.2B. The gels could be formed in situ
within averages of 15 min, for the gel with TMV-SH, and 2 h, for the gel without TMVSH.
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Figure 6.2. Gelation behavior of injectable hydrogels was observed via oscillation time sweep at 25 °C, 2% strain and 10 rad/s
frequency. (A) The gel with the crosslinked virus gelled faster and yielded stable solid-like structure hydrogel with higher storage
modulus. (B) The average gelation time of TMV-gel was significantly faster than that of the control HA gel. (B inset) The structured
hydrogel with virus particles formed when the control hydrogel mixture was still in viscous liquid after fabricated at the same time.
The horizontal bars are means ± SD with each data expressed in dot plots (n = 3); *p < 0.05.

The mechanical properties of TMV-SH+HA and control HA hydrogels were
assessed through oscillatory rheology. Usually the rheological properties of a viscoelastic
material are independent of strain up to a critical strain level γc. Beyond this critical strain
level, the material’s behavior is non-linear and the storage modulus declines. A strain
sweep will establish the extent of the material’s linearity. Figure 6.3A showed a strain
sweep for both types of hydrogel giving higher average G′ of TMV-SH, 0.1% + 30DMHA (435.60 Pa) than that of 30-DMHA, 5% (304.79 Pa). The critical strain γc of
TMV-SH, 0.1% + 30-DMHA, 5% was approximately 400%, while 30-DMHA, 5% alone
showed γc at ~ 200%. Below γc, the structure is intact, the material behaves solid-like,
and G′ > G″, indicating that the material is highly structured. Increasing the strain above
the critical strain disrupts the network structure. This result suggested that the gel with
TMV-SH was stiffer than the control HA gel.
In oscillation analysis, frequency sweep is used to characterize materials’
structures. It can be used to determine if a material is a three-dimensional network (gel),
an entangled solution (paste), or a particle solution (liquid).206 From Figure 6.3B, the
elastic and loss moduli of both gels was essentially frequency-independent (G′ ∝ ω0.01 Hz)
and very slightly frequency-dependent, respectively; with elastic moduli higher than loss
moduli. This viscoelastic behavior defined material’s structure as 3D network of a
hydrogel consisting of permanent crosslinks. As the test continued within a wide
frequency range of 0.01 - 9, the gel maintained its solid-like viscoelasticity (G′ > G″)
confirming its high resistance to deformation and subsequent high yield value.206, 207
Further analysis on this frequency sweep experiment revealed that TMV-SH modified
HA gel developed better solid-like behavior by decreasing the loss tangent (tanδ
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G″/G′)
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Figure 6.3. Viscoelastic properties of HA hydrogels with and without TMV particle. (A) Amplitude sweeps at 1 Hz frequency showed
that TMV-SH modified HA gel increase the critical strain and elastic modulus of the hydrogel. (B) Frequency sweeps at 2% strain
amplitude confirmed the increase in gel modulus with TMV-SH modified hydrogel (n = 3). Each plot expressed mean ± SD.

from 0.033 to 0.015. From this test, the average G′ ± SD (taken from the frequencyindependent range, n = 3) of TMV-SH, 0.1% + 30-DMHA, 5% and 30-DMHA, 5% gel
were calculated 422.89 ± 26.60 Pa and 273.25 ± 23.29 Pa, respectively. This analysis
confirmed the result from amplitude sweep that the crosslinked TMV-SH increased the
storage modulus of 30-DMHA, 5% gel.

6.2.3 Presentation of TMV-1Cys in HA hydrogels
MALDI-TOF analysis was used to determine the crosslinking between TMV-1Cys and
HA backbone after fabrication of hydrogel. The TMV-SH, 0.1% + 50-DMHA, 5%
hydrogel was first digested using 1800 units HAase (Hyaluronidase enzyme) for 48 h.
The digested-hydrogel solution was then mixed with matrix, dropped on target plate, and
subjected to MALDI-TOF analysis. The 2 controls included 1) purified TMV-1Cys in 10
mM potassium phosphate buffer, pH 7; and 2) 50-DMHA, 5% hydrogel digested with
900 units HAase as shown in the last 2 bottom panel of Figure 6.4A. HAase randomly
cleaves β-N-acetylhexosamine-[1→4] glycosidic bonds in hyaluronic acid. Figure 6.4A
demonstrated that TMV-SH gel obtained pronounced peaks in addition to the peak of
original TMV-SH coat protein (around 17630 m/z). One of the additional peaks appeared
at 19652 m/z. From this representative peak, the mass difference subtracted from the
TMV-1Cys peak was calculated and matched with the molar mass of the possible
backbone structure proposed in Figure 6.4B.
To confirm the existence of TMV-1Cys particles in the methacrylated HA
hydrogel, spin coating technique following with atomic force microscopy were applied.
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Figure 6.4. Interaction of TMV-1Cys and its structural integrity in modified-HA
hydrogel. (A) MALDI-TOF spectra compared the m/z profiles of TMV cys-mutant
functionalized hydrogel after enzyme digestion of HA backbone (top panel) with the
virus alone (middle panel) and with the control HA hydrogel (last panel). The extra peak
marked in the top panel was analyzed to match the structure proposed in (B). (B) From
MALDI-TOF analysis, the TMV-1Cys was shown to have a covalent interaction with the
polymer backbone. (C) AFM height image (spin coated) showed the presence of TMV1Cys intact particles in the hydrogel.
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The TMV-SH, 0.1% + 50-DMHA, 5% hydrogel, after adding DTT and allowing 10 min
gelation, was spin-coated on the silicon wafer. The hydrogel coated wafer was then dried
and subjected to AFM imaging. Figure 6.4C showed the height profile of TMV-1Cys
particles on the silicon wafer substrate coated with TMV-incorporated hydrogel, which
confirmed the existence TMV particles in the hydrogel. TMV-1Cys has the same
appearance with wild-type TMV observed by AFM (See appendix G).

6.2.4 Microstructural characterization of hydrogels
As described earlier in chapter 1, the high porosity and interconnectivity of hydrogel are
critical for cell survival in vitro, when the capillaries are not present, since these
properties influence cell migration and diffusion of oxygen, nutrients, waste products and
signaling molecules.148, 208, 209 The extent of ECM secretion also increases by increasing
the pore size. It was found that in genipin crosslinked gelatin hydrogels with smaller
pores, the tendency was tilted toward cell growth rather than of ECM secretion, resulting
in over-confluence during the middle and late stages of differentiation; consequently, the
extent of ECM secretion decreased compared to that within gelatin hydrogels with larger
pores.210 The effect of implant pore size on tissue regeneration is emphasized by
experiments demonstrating the optimum pore size of 5 µm for neovascularization, 5–15
µm for fibroblast ingrowth, 20 – 125 µm for regeneration of adult mammalian skin, 100 –
350 µm for regeneration of bone, 40 – 100 µm for osteoid ingrowth, and 20 µm for the
ingrowth of hepatocytes.211 In addition, mean pore size has been shown to impact the
amount of contraction a graft will undergo after implantation. An average pore diameter

131

of 20 – 125 µm was required for contraction-inhibiting activity to be observed in
collagen–glycosaminoglycan graft copolymers used for dermal repair.212 To characterize
the microstructure of our HA gels, we used scanning electron microscopy (SEM) for
imaging hydrogels after freeze-drying (Figure 6.5). The cross-section electron
micrograph of TMV-SH, 0.1%+100-DMHA, 3% revealed 20 - 100 µm range of interior
pore size with high porosity and interconnectivity. Furthermore, the thin, dense, sheetlike layers of polymer extending along the outer edge of the hydrogel cross-section were
observed (Figure 6.5). 100-DMHA, 3% obtained the similar pore architecture except the
lesser inter-connectivity with more well-defined pore structure and the thicker layer of
dense outer edge (Figure 6.5). Besides, the exterior surfaces of both gels were dense,
rough, folded architecture with sub-micron sized pores (< 2 µm). This surface layers were
uniform and continuous, which made the surface essentially less porous. This result was
consistent with previous studies of HA hydrogels. 213-215
Apart from the porosity, permeability also has a remarkable effect on proliferation
and phenotype of cells.148, 216 Here, we investigated the permeability of the hydrogels by
observing the fluorescent dye diffusion. First, the standard curve of Fluoresceinamine
isomer I in PBS was generated from 1 - 10 µg/mL concentration range (See Appendix
H). The amount of dye diffused into the pre-saturated hydrogel was calculated from the
reduction of fluorescence intensity measured from the medium over time. Figure 6.6
showed that both hydrogels, TMV-SH, 0.1%+50-DMHA, 5% and 50-DMHA, 5%, could
absorb the dye in a similar manner. The dye diffusion reached equilibrium within one
hour in both hydrogels. The value of dye diffusion presented in Figure 6.6 depicted the
dye concentration in the hydrogel percentages of the total dye concentration in the media
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Figure 6.5. Cross-section and surface SEM micrographs of virus-modified injectable
hydrogel. The cross-section ESEM images showed the porous interior architecture of
both hydrogel after freeze-dried. The virus incorporated hydrogel obtained larger extent
of interconnecting channels with thinner dense layers along the outer edge. The exterior
surfaces of both hydrogels seemed denser with sub-micron pore architecture.
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Figure 6.6. Permeability of the hydrogels in term of molecular diffusion was tested using
dye diffusion study. The hydrogel functionalized with virus particles allowed faster rate
and better diffusion of the fluorescent dye when incubated at 37°C. Each plot represented
means ± SD (ANOVA, p = 0.05).
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with the hydrogel altogether (theoretical). TMV-SH, 0.1%+50-DMHA, 5% gel absorbed
slightly more dye at equilibrium around 100% on average comparing to the value
calculated for the 50-DMHA, 5% gel, which was around 75% (p = 0.05). This might be a
consequence from the pore and interconnect structural differences discussed earlier.

6.2.5 Swelling property and stability of hydrogels
To exploit swelling property of each hydrogel, 250 µL of TMV-SH, 0.1%+50-DMHA,
5% and 50-DMHA, 5% hydrogels were fabricated and immersed in 1 mL PBS. The
representative of fully structured hydrogel before incubation with PBS was shown in
Figure 6.7A inset. Swelling ratio of HA hydrogel with TMV-1Cys was shown to be
slightly higher than the control HA gel without the virus nanoparticle in early time points
(Figure 6.7A). However, the swelling ratios of both hydrogels became insignificantly
different at later time points. This, as well, could be a result of the higher
interconnectivity and the thinner wall of TMV-SH, 0.1%+50-DMHA, 5% gel observed
from the cross-section scanning electron micrograph. This microstructure of TMV-SH,
0.1%+50-DMHA, 5% gel allowed better water absorption and could entrapped higher
volume of aqueous media at faster rate in comparison to 50-DMHA, 5% gel. Slight
increases in swelling ratios were observed during the 120 h incubation, which could
indicate a possible onset of the degradation of the hydrogel. Stability of both hydrogels
was shown in Figure 6.7B. No weight loss was observed within 21 days in PBS.
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Figure 6.7. Swelling properties and stability of the hydrogels. The hydrogel after gelation (A inset) was immersed into PBS (A) The
weight change due to water absorption was monitored over time. Swelling rate appeared faster with the TMV-SH modified hydrogel.
(B) No weight decreases were observed from both hydrogels measured after freeze-drying at each time point for up to 3 weeks
incubation. The values expressed are means ± SD, n = 3.

6.2.6 In situ encapsulation and culture of bone marrow stromal cells in 3D hydrogel
We next explored the compatibility of TMV-1Cys HA hydrogel for culturing BMSCs.
BMSCs were encapsulated in situ by mixing the cells (1 million /mL) thoroughly with
TMV-SH, 0.1%+50-DMHA, 5% and 50-DMHA, 5% pre-hydrogel solutions in complete
DMEM cell culture media before loading into Transwell® inserts. Metabolic rate of
BMSCs encapsulated in the hydrogels TMV-SH, 0.1%+50-DMHA, 5% and control
hydrogel 50-DMHA, 5% was carried out at different time points using CellTiter-Blue®
(CTB) reagent. Metabolite of CTB reagent generated by viable cells is fluorescent. Figure
6.8 showed the preliminary result from each hydrogel, n = 1. The cell metabolic rates in
both hydrogels were similar. On day 4, the metabolic rates decreased from the first day of
culture, and then increased continuously until the end point on day 15. Cell viability was
then confirmed by live-cell staining, Calcein AM (CAM), at different time points. Figure
6.9 illustrated the viable cells in both hydrogels stained green from day 9 and 17.

6.2.7 RNA extraction for future gene study
For application in BMSC differentiations, this cell-encapsulated hydrogel culture was
validated for RNA extraction. We were able to purify RNA in the sufficient amount and
quality for the future gene expression studies. Figure 6.10 showed an agarose gel with
polymerase chain reaction (PCR) products of GAPDH, a house keeping gene, which was
synthesized from cDNA of mRNA purified from cells cultured in TMV-SH, 0.1%+50DMHA, 5% at different time points.
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Figure 6.8. Celltiter Blue assay of viable cells encapsulated at a concentration of 1 M/mL
in the hydrogels in primary media culture.
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Figure 6.9. Live cell staining of BMSCs cultured in hydrogels. BMSCs were embedded
into the 3D hydrogel, in situ, at 1 million cells/mL concentration in complete primary
media. Day 9 and 17 live cell staining was shown using Calcein AM staining.
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Figure 6.10. Agarose gel image of PCR product derived from mRNA of BMSCs cultured
in hydrogels. Sufficient amount of RNA could be isolated from the culture. Gel image
shows the PCR product of house-keeping gene from RNA isolated on day 6 (lane 2), 10
(lane 3, 4), and 18 (lane 5).

140

6.3 CONCLUSION
HA hydrogel can be engineered to obtain different properties. HA backbone could be
modified to have the reactive methacrylic group and the gel can be formed in situ after
addition of DTT crosslinker via Michael addition reaction under physiological condition.
The incorporation of TMV particles could be preceded through the same thiol-ene click
reaction between thiol group of TMV-1Cys mutant and the methacrylated HA polymer.
The gelation time was improved after addition of TMV-1Cys to 12 minute allowing
adequate operation time, yet providing sufficiently rapid rate for clinical efficacy. The
resulting gel obtained the micro-and macro-pore structures enabling an exchange of
nutrients. The mechanical property of hydrogel could be enhanced by incorporation of
TMV-1Cys nanoparticles. The hydrogel was compatible for stem cell culture, and genetic
material could be extracted for further gene analysis. This study is considered a
foundation of the development of injectable hydrogel with TMV covalently linked to the
back-bone polymer that can be further functionalized to direct the encapsulated cell
responses in 3D.

6.4 EXPERIMENTAL SECTION
All chemicals were obtained from commercial suppliers and used as received unless
otherwise noted. Wild-type TMV (TMV) and its Cys-mutant (TMV-1Cys) were isolated
from infected tobacco leaves following previously established protocols.26
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6.4.1 HA-methacrylate synthesis
Synthesis of HA-methacrylate was modified from the method originally described by
Smeds et al.217 according to the protocol detailed by Marklein et al.218 Briefly, HA of
molecular weight 47, 310,or 1000 kDa (Dali) was dissolved at 1 wt% in potassium
phosphate buffer, pH 8 and methacrylic anhydride (Alfa Aesar) of different folds molar
excess (relative to the HA disaccharide repeat unit) as listed in Table 1 was added
dropwise to the solution on ice. The pH of the two-phase reaction mixture was adjusted to
8.0 with 5 M NaOH, and the reaction was allowed to continue for 24 h. at 4 °C with
frequent re-adjustment of the pH. The product was dialyzed against milli-Q water for at
least 48 h, followed by centrifugation to recover the precipitate, which was then flash
frozen in liquid nitrogen, and lyophilized. The powder thus obtained was analyzed by 1H
NMR.

6.4.2 HA gelation and rheology
In general, to form crosslinked HA gels, HA-methacrylate polymers with 30-50%
degrees of functionalization (hereafter denoted as xx-DMHA; with xx represented %
degree of modification) was dissolved in phosphate buffer saline (PBS) at the desired
concentration. The crosslinker dl-dithiothreitol (DTT) was added at the ratio of thiol:ene
1:4. For “TMV-SH, 0.1% + xx-DMHA, 5%”, xx-DMHA was dissolved in PBS at 5 wt
% concentration, and 10 mg/mL TMV-1Cys was then added before adding DTT to make
final concentration of 0.1 wt %. Oscillatory shear rheology was performed using a DHR3 rheometer (TA instrument) with 12 mm diameter parallel-plate geometry and
temperature controlled peltier plate. For the gelation study, the gels were crosslinked in
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situ between the rheometer plates in a close chamber protecting hydrogel from
dehydration. The measurement in oscillatory time sweep mode (2% strain amplitude, 10
rad/s) immediately started after the freshly prepared pre-hydrogel mixture was loaded on
the peltier plate. Typically, 200 µL of the gel solution was used with a gap width of 1 mm
between the plates. Amplitude sweeps at constant frequency (1 Hz) were performed to
determine the linear viscoelastic range of deformation for each sample, after which
frequency sweeps (0.01-100 Hz) were performed at a strain amplitude within the linear
range (2%). In amplitude and frequency sweeps measurement, the geometry gaps were
conditioned by axial force at 0.5 N for every run.

6.4.3 MALDI-TOF analysis
The 100 μL of pre-formed TMV-SH hydrogel was digested using 1800 U HAase in 1 mL
PBS (Type IV-S from bovine testes, Sigma) for 2 days. The control hydrogel without the
virus was digested with the 900 U HAase in 200 μL PBS. Each sample was prepared by
mixing the virus (0.5 mg/mL, 1 μL) or digested hydrogels solution (1 μL) with 9 μL of
matrix solution (saturated sinapic acid in 70% acetonitrile, 0.1% trifluoroacetic acid).
ne μL of the mixture was spotted on a MALDI plate, air-dried and analyzed by
MALDI-TOF mass spectrometry (Bruker Ultraflex MALDI-TOF/TOF).

6.4.4 Atomic force microscopy of TMV-SH hydrogel
Atomic force microscopy (AFM) was performed on the TMV-SH, 0.1% + 50-DMHA,
5% hydrogel. First, 5% methacrylated HA polymer solution in PBA, after adjusting pH to
pH 8, was mixed with TMV-1Cys to make 0.1 wt % final concentration. DTT was added
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to the mixture. After 10 min gelation, the hydrogel was spin-coated on the silicon wafer.
The hydrogel coated wafer was then dried and subjected to AFM imaging. The TMV1Cys in the hydrogel on the wafers was characterized using tapping-mode AFM images
using a NanoScope IIIA MultiMode AFM (Veeco). Si tips with a resonance frequency of
approximately 300 kHz, a spring constant of about 40 Nm-1 and a scan rate of 1.0 Hz
were used.

6.4.5 Environmental scanning electron microscopy
Environmental scanning electron microscopy (ESEM) images were obtained by VEGA3
TESCAN electron microscope. Freeze dried samples were cross-sectioned and mounted
on aluminum stubs with carbon tape. Samples were observed under a low vacuum with
20 kV of electron acceleration and a 9.95 -13.16 mm working distance.

6.4.6 Dye diffusion study
After the 150 µL hydrogels were fabricated as mentioned earlier, each gel was soaked
into 400 µL of 5 µg/mL fluoresceinamine isomer I (sigma) in PBS. The amount of dye
diffused into the hydrogel was calculated from the left-over dye detected from the
medium. Dye amounts were transformed from fluorescence intensity measured at
490/520 nm (Ex/Em) by SpectraMax M2 Multi-Mode microplate reader (Molecular
Devices). The standard curve was generated from different dye concentrations in the
range of 1-10 µg/mL plotted over fluorescence intensities. The amounts of dye diffusion
were then calculated into concentrations of dye in the hydrogels and normalized against
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the concentrations of dye in total volume (hydrogel volume + medium volume) as shown
in the following equation.
Dye concentration diffusion percentage
amount of dye in hydrogel/hydrogel volume
amount of dye in total/(hydrogel volume dye solution volume)

6.4.7 Swelling property and stability
Swelling property of each hydrogel was determined by the final weight divided by the
initial weight of the hydrogel. The initial weights (~ 250 mg) of hydrogels were recorded
(µ0). Hydrogels were immersed in 1 mL PBS at room temperature, and then the weights
after immersion over time were recorded (µt). Surrounding water was drained and blotted
out with Whatman filter paper from hydrogels before weighing. The swelling ratios were
calculated from μt/μ0. For stability test, pre-formed hydrogels (250 µL) were incubated
with 1 mL of PBS at room temperature. The hydrogel mass reduction at each time point
was monitored. The hydrogel was collected and lyophilized for at least 24 h. before the
dry weight was measured. The dry weight at the starting point was measured as γ0 (~ 16
mg). The dry weight measured at different time point was symbolized γt. Normalized
hydrogel dry weight was calculated as γt/ γ0.

6.4.8 Bone Marrow Stem Cells (BMSCs) isolation and culture
Primary BMSCs were isolated from the bone marrow of young adult 160 - 180 g male
Sprague Dawley rats (Charles River Laboratories). The procedures were performed in
accordance with the guidelines for animal experimentation by the Institutional Animal
Care and Use Committee, School of Medicine, University of South Carolina. Cells were
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maintained in complete primary media (Dulbecco’s Modified Eagle’s Medium (DMEM)
supplemented with 10% fetal bovine serum (FBS)), kept at 37 ⁰C in a CO2 incubator with
5% CO2 : 95% air and passaged no more than seven times after isolation.

6.4.9 In situ cell encapsulation with hydrogel matrix
The hydrogels were prepared s previously described, except that the preparation occurred
under sterile condition and pre-warmed complete DMEM media was used to dissolve the
polymer. TMV-1Cys was filtered to remove all pathogen before mixing. All other
components including 5 M NaOH and 0.2 M DTT in PBS were also sterile filtered with
0.2 µm PES membranes. BMSCs were harvested from the tissue culture plate after
reaching 80% confluency. The cells were then mixed with the mixture of pre-warmed
hydrogel in DMEM media at 1 M/mL concentration right after addition of DTT. One
hundred and fifty microliters of the cells-hydrogel mixture was then injected into each
Transwell (Corning) that was inserted and anchored in 24 well tissue culture plate, and
incubated at 37 ⁰C in a CO2 incubator with 5% CO2 : 95% air. Approximately 6 h after
casting the gel into Transwell, 400 µL additional DMEM media was added into each
well. The fresh media was exchanged every day for the entire experimental period.

6.4.10 Cell metabolic rate
CellTiter-Blue® (CTB) cell viability assay (Promega) after day 1, 4, 8 and day 15 of
culture was performed in a separate sample for each type of hydrogel. The culture media
in each well was replaced by 300 mL of pre-warmed media containing 15% CTB and
incubated for 20 h at 37 °C and 5% CO2. The media containing CTB was used without
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cells as negative controls. The media containing metabolite of CTB was measured for
fluorescence intensity at 560/590 nm (Ex/Em) using SpectraMax M2 Multi-Mode
microplate reader (Molecular Devices).

6.4.11 Live cell staining
On day 9 and 17 of cell culture, 10 μg/mL of calcein AM in media was added in each
cell-hydrogel culture well and incubated for 30 minutes in 37°C. Then, hydrogels in each
well were washed by PBS. After washing, PBS was replaced with fixative solution (4%
paraformaldehyde in 1× Dulbecco's Phosphate Buffered Saline; DPBS). Hydrogels were
fixed overnight at 4 °C. Fixed hydrogels were then washed with PBS 3 times and stored
in PBS. Images of the stained samples were obtained using Olympus IX81 with DSU
confocal mode.

6.4.12 RNA isolation
At the cell culture end point, total RNA could be purified from the hydrogel. First, each
hydrogel was preserved in RNA later (Qiagen) overnight at 4°C. This step was critical to
help protecting RNA from degradation during complex isolation procedures. The
preserved hydrogel was then disrupted by high speed homogenization. The tissue
homogenizer probe was rinsed with RNase-free water and 10% sodium lauryl sulfate
between each sample processing to prevent cross-contamination. Total RNA was
subsequently extracted following manufacturers’ protocols of either QIAShredder
(Qiagen) with E.Z.N.A. Total RNA Kit (Omega) or RNAzol® RT (MRC). The resulting
RNA was reverse transcribed by using qScript™ cDNA Supermix (Quanta Biosciences).
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RT-PCR was then achieved by the method described as: 45 cycles of PCR ( 95°C for 20s,
58°C for 15 s, and 72°C for 15 s), after initial denaturation step of 5 minutes at 95°C, by
using 0.1 μL of Taq DNA polymerase, 0.5 μL of 10 mM dNTP Mix, 2.5 μL of 10× PCR
Buffer, without Mg, 2 pmol/μL of each forward and reverse primers and 30 ng cDNA
templates in a final reaction volume of 25 μL. Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) was used as an example gene. Here, we used GAPDH primer
sequence from the report by Sitasuwan et al.17 The PCR product was then subjected to
standard agarose DNA gel electrophoresis.
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APPENDIX A – COPYRIGHT CLEARANCE FOR CHAPTER 1
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APPENDIX B – ALIZARIN RED STAINING ON SCAFFOLDS

Figure B.1. Alizarin Red staining on controls (A) PAH, (B) TMV-PAH, and (C) RGDPAH without BMSCs showed lighter color (pink) compared to the cultured hydrogels.
Scale bar = 2 mm.
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APPENDIX C – TMV-FLUORESCEIN

Figure C.1. MALDI-TOF characterization of fluorescein-modified wild-type TMV.

177

Figure C.2. Fluorescence spectrum of fluorescein-modified wild-type TMV.
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Figure C.3. Fluorescence spectroscopy calibration with linear fitting curve and equation
for quantification of fluorescein-modified wild-type TMV.
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APPENDIX D – TWO DIMENSIONAL CONSTRUCTS OF BONE EXCISES

Figure D.1. Two dimensional constructs of bone excises from rats with PAH, TMVPAH, and RGD-PAH implanted.
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APPENDIX E – REPRESENTATIVE 1H NMR SPECTRA OF METHACRYLATED HA
A

B

C

Figure E.1. 1H NMR spectra of methacrylated HA with 10% (A), 38% (B), and 100%
(C) degree of modification.
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APPENDIX F – TEM ELECTRON MICROGRAPH OF TMV-1CYS

500 nm

Figure F.1. Transmission electronmicrograph of TMV-1Cys.
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APPENDIX G – AFM IMAGE OF WILD-TYPE TMV

Figure G.1. Atomic force microscopy of wild-type TMV.
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APPENDIX H – STANDARD CURVE FOR DYE DIFFUSION STUDY

Figure H.1. Fluorescence spectroscopy calibration with linear fitting curve and equation
for quantification of fluorescein amine isomer I.
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